CEDNIK Syndrome

Mendelian MONDO:0012290 Pathograph 70 Show in embeddings browser autosomal recessive disease neurocutaneous syndrome rare disease

CEDNIK syndrome is an autosomal recessive SNAP29-related neurocutaneous disorder with variable developmental impairment, brain malformations, peripheral neuropathy, ichthyosis and palmoplantar keratoderma. Some molecularly confirmed individuals lack skin disease or cortical malformations. Loss of SNAP29 function disrupts selected membrane-trafficking pathways; patient skin demonstrates abnormal lamellar granules and retention of lipid and protease cargo. Cell models identify endocytic recycling, Golgi organization and mitotic defects, but the causal routes to human brain malformations remain incompletely resolved. Hypomyelination and later neurological regression broaden the disorder beyond a purely congenital malformation syndrome. Biallelic sequence variants or a pathogenic sequence variant opposite a deletion encompassing SNAP29 can cause disease; other deleted genes can contribute additional features.

Ask OpenScientist

Ask a research question about CEDNIK Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🔗

Mappings

MONDO

MONDO:0012290 CEDNIK syndrome

👪

Inheritance

Autosomal recessive inheritance HP:0000007

Autosomal recessive inheritance with homozygous or compound heterozygous pathogenic SNAP29 variants. Two sequence variants can occur in trans, or a sequence variant can be paired with a deletion encompassing SNAP29. Carrier parents are generally unaffected; feature-specific variability does not demonstrate incomplete penetrance of the entire recessive disorder.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:15968592 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Using homozygosity mapping in two large families, we localized the disease gene to 22q11.2"

The founding families establish recessive inheritance.

PMID:31748968 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Exome sequencing in the trio revealed novel compound heterozygous pathogenic mutations in SNAP29 (p.Leu119AlafsX15, c.354DupG and p.0?, c.2T > C)."

The molecularly confirmed case demonstrates two different sequence alleles; the variant details are provided in the available abstract.

Discussions and Knowledge Gaps

What does loss of SNAP29-dependent vesicle fusion do in the developing brain to produce corpus callosum dysgenesis and polymicrogyria?

KNOWLEDGE GAP cednik_brain_mechanism

Attached to

pathophysiology#Abnormal Neural Development pathophysiology#Defective Mitotic Chromosome Segregation

Human neuroepithelial stem-cell knockdown establishes Golgi, spindle and nuclear abnormalities; patient fibroblasts show defective recycling and motility. The unresolved question is which of these routes causes specific human malformations or myelin loss. Patient-derived neural models with isogenic correction and developmental readouts could distinguish these contributions.

Which allele-dependent and background-dependent factors explain variable skin, myelin and developmental manifestations?

KNOWLEDGE GAP cednik_expressivity

Attached to

genetic#SNAP29

The start-loss siblings have relatively preserved skills, yet one later regressed; skin-negative compound heterozygotes and variable keratoderma are documented. Protein mislocalization, residual translation and genetic background are distinguishable hypotheses. The mouse background effect demonstrates a model modifier effect, not a proven human modifier.

When does SNAP29 loss impair autophagic clearance, and how much does this contribute to human skin and neurological disease?

HUMAN MODEL MISMATCH cednik_autophagy_contribution

Attached to

pathophysiology#Context-Dependent Autophagic Clearance Disturbance pathophysiology#Endoplasmic Reticulum Stress

The 2016 static LC3-II/p62/CHOP measurements were made in primary mouse fibroblasts and cannot distinguish induction from reduced clearance. Zebrafish and mouse ESCs show different marker responses, with a SNAP47-dependent effect in ESCs. Flux assays with appropriate turnover controls in patient keratinocytes and neural cells, alongside isogenic rescue, would test the contribution to human disease.

Which model backgrounds reproduce the human cortical and epidermal phenotypes?

HUMAN MODEL MISMATCH cednik_model_brain_skin_divergence

Attached to

animal_models#Mixed CD1/FvB Snap29 exon-2 knockouts animal_models#snap29 K164* and N171fs zebrafish

Mixed-background mice survive with a functional neonatal barrier and no detectable cortical malformations. Zebrafish have a thinner periderm rather than hyperkeratosis. These divergences matter when selecting readouts for rescue experiments; neurological or skin improvement in one model does not demonstrate correction of the corresponding human mechanism.

⚙

Pathophysiology

SNAP29 Loss of Function

Mechanism confidence: Established

Biallelic pathogenic variants reduce functional SNAP29. Protein abundance and localization depend on the allele: the founding deletion reduced RNA and protein, whereas the Ser163 frameshift can produce a truncated, mislocalized protein. Residual translation from the c.2T>C start-loss allele and nonsense-mediated-decay escape of p.Glu208* remain predictions.

SNAP29 hgnc:11133

Genetic context variant_origin: GERMLINE functional_impact_category: LOSS_OF_FUNCTION

Experimental models

CRISPR SNAP29-null MRC5Vi fibroblast clone CELL LINE Removes detectable SNAP29 in a human cell line.

Downstream

Lamellar Granule Maturation Failure Reduced SNAP29 expression in patient skin is associated with abnormal granule maturation and cargo retention.

Impaired Endocytic Recycling Loss of SNAP29 in patient fibroblasts impairs transferrin and integrin recycling; initial uptake is preserved.

Golgi Organization Defects SNAP29 depletion disrupts Golgi organization, with restoration after RNAi-resistant SNAP29 expression in human cells.

Defective Mitotic Chromosome Segregation SNAP29 depletion interferes with kinetochore assembly and chromosome segregation in human cell models.

Abnormal Cerebral Myelination Biallelic variants are associated with hypomyelination or later myelin loss; the responsible cellular pathway remains unresolved.

Context-Dependent Autophagic Clearance Disturbance SNAP29 loss perturbs autophagy-marker and organelle readouts in some models, with dependence on cell state and paralog compensation.

Endoplasmic Reticulum Stress Snap29-null primary mouse fibroblasts show increased CHOP, providing a model-specific stress response.

Altered Motor Neuron Organization Zebrafish snap29 mutation alters trigeminal motor nuclei and axon branching; applicability to individual human manifestations is unresolved.

Peripheral Nerve Myelin Dysfunction Biallelic SNAP29 dysfunction is associated with peripheral demyelinating neuropathy; the intervening cellular pathway is unknown.

Impaired Swallowing Neurological dysfunction can impair swallowing; the precise tissue and molecular contributors are unresolved.

Show evidence (3 references)

PMID:15968592 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"SNAP29 expression was decreased in the skin of the patients"

The founding allele reduces expression in patient tissue.

PMID:21073448 SUPPORT DIRECT PRIMARY RESULT In Vitro

"In vitro transfection experiments indicated that this mutation results in SNAP29 loss-of-function."

The second family allele was tested by transfection.

PMID:33977139 SUPPORT DIRECT BACKGROUND In Vitro

"Cell culture experiments suggest that the mutated protein is produced at normal levels with abnormal localization."

The cohort cites the earlier Ser163 frameshift experiments; this is experimental background, not a new protein assay in the cohort.

Lamellar Granule Maturation Failure

Mechanism confidence: Established

Patient epidermis contains abnormal clear vesicles alongside residual normal lamellar granules. Defective maturation and secretion mislocalize lipid and protease cargo; the defect is not complete absence of all granules.

keratinocyte CL:0000312

epidermal lamellar body GO:0097209

Animal models

C57BL/6 global and keratinocyte-specific Snap29 knockouts Mus musculus partially recapitulates Models abnormal granules and reduced cargo secretion.

Downstream

Reduced Extracellular Epidermal Lipid Delivery Abnormal granules fail to deliver lipid cargo normally.

Epidermal Protease Cargo Retention Abnormal granules retain protease cargo.

Abnormal Keratinocyte Differentiation Disrupted granule function contributes to abnormal epidermal maturation.

Show evidence (1 reference)

PMID:15968592 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"abnormal maturation of lamellar granules and, as a consequence, in mislocation of epidermal lipids and proteases."

Patient skin directly supports disturbed granule maturation and cargo delivery.

Reduced Extracellular Epidermal Lipid Delivery

Mechanism confidence: Established

Glucosylceramides are retained within abnormal intracellular compartments rather than being delivered normally to the extracellular stratum corneum. This compromises the lipid lamellae that contribute to the permeability barrier.

Downstream

Epidermal Barrier Impairment Reduced delivery disrupts extracellular barrier lipids.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"In the skin of our patients, considerable amounts of glucosylceramides were retained, abnormally, within the cells of lower stratum corneum"

The founding patient-skin immunoelectron microscopy localizes lipid cargo abnormally.

Epidermal Protease Cargo Retention

Mechanism confidence: Established

Patient corneocytes retain KLK5 and KLK7 in abnormal vesicles. Reduced extracellular delivery limits the proteolysis needed for normal shedding of corneocytes.

Downstream

Impaired Corneocyte Desquamation Reduced extracellular protease availability impairs corneodesmosome degradation.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Abnormal vesicles in the cornified cells were also found to contain KLK5 and KLK7, two proteases of major importance for normal desquamation"

Patient-skin localization identifies the affected protease cargo.

Impaired Corneocyte Desquamation

Mechanism confidence: Provisional

Defective delivery of lamellar-granule proteases provides a route to impaired corneodesmosome degradation and retention hyperkeratosis. Corneodesmosin remnants are demonstrated in SNAP29-deficient model epidermis.

Downstream

Ichthyosis Retention of corneocytes contributes to scaling.

Palmoplantar keratoderma Impaired shedding contributes to palmoplantar thickening.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT INDIRECT PRIMARY RESULT Model Organism

"These findings indicate a delay in degradation of Cdsn due to reduced amounts of kallikrein 7."

The mouse study connects reduced protease availability with retained corneodesmosin; translation to patient desquamation is supported by the shared cargo defect.

Epidermal Barrier Impairment

Mechanism confidence: Provisional

Abnormal extracellular lipid organization impairs skin-barrier function. Direct dye-permeability and dehydration assays show a severe defect in the C57BL/6 keratinocyte knockout; the mixed-background mouse instead establishes a functional barrier by birth.

establishment of skin barrier GO:0061436 ↓ DECREASED

Animal models

C57BL/6 global and keratinocyte-specific Snap29 knockouts Mus musculus partially recapitulates Directly tests permeability and water loss.

Mixed CD1/FvB Snap29 exon-2 knockouts Mus musculus fails to recapitulate Tests delayed prenatal barrier acquisition followed by normalization.

Downstream

Ichthyosis Barrier impairment contributes to the ichthyotic phenotype.

Show evidence (2 references)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT PRIMARY RESULT Model Organism

"Both experiments indicate severe functional impairment of the epidermal barrier."

Dye intrusion and dehydration directly test the barrier in mutant mice.

PMID:31633066 REFUTE DIRECT PRIMARY RESULT Model Organism

"although skin barrier formation is delayed in homozygous mutant embryos, a proper skin barrier was present at birth."

The mixed-background model limits generalization of the neonatal barrier defect.

Abnormal Keratinocyte Differentiation

Mechanism confidence: Established

SNAP29 depletion alters epidermal differentiation in human organotypic cultures and mouse epidermis. The mouse phenotype includes abnormal differentiation-marker distribution and hyperproliferation; its acanthosis and neonatal lethality exceed the typical human skin phenotype.

keratinocyte CL:0000312

keratinocyte differentiation GO:0030216 ⚠ ABNORMAL

Experimental models

SNAP29-knockdown three-dimensional human keratinocyte organotypic culture OTHER Models differentiation changes in human epidermal culture.

Animal models

snap29 K164* and N171fs zebrafish Danio rerio fails to recapitulate Compares mutant epidermal organization with mammalian skin.

Downstream

Ichthyosis Abnormal cornification contributes to scaling.

Palmoplantar keratoderma Abnormal cornification contributes to keratoderma.

Show evidence (1 reference)

PMID:21073448 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we could replicate histological features typical for CEDNIK syndrome in three-dimensional primary human keratinocyte organotypic cell cultures downregulated for SNAP29."

Human organotypic cultures reproduce histological features after SNAP29 knockdown.

Impaired Endocytic Recycling

Mechanism confidence: Established

Two transformed patient fibroblast lines show delayed transferrin and beta-1-integrin recycling, enlarged early/recycling endosomes and abnormal focal-adhesion distribution. Transferrin uptake, VSVG secretory transport and cholera-toxin-B retrograde transport were preserved in these assays.

Experimental models

CEDNIK patient-derived transformed fibroblasts CELL LINE Measures patient-cell recycling kinetics.

Downstream

Reduced Fibroblast Motility Defective integrin recycling can impair focal-adhesion turnover and cell movement.

Show evidence (1 reference)

PMID:20305790 SUPPORT DIRECT PRIMARY RESULT In Vitro

"During the chase times, disappearance of transferrin from CEDNIK cells was attenuated by 26–30% compared to control cells"

The patient-fibroblast study distinguishes recycling defects from preserved uptake and selected other trafficking routes.

Reduced Fibroblast Motility

Mechanism confidence: Established

Patient fibroblasts show delayed spreading and wound closure in association with altered integrin recycling and focal adhesions. Extension to neuronal migration is a hypothesis, not a direct measurement in patient brain.

Experimental models

CEDNIK patient-derived transformed fibroblasts CELL LINE Measures spreading and wound closure.

Downstream

Abnormal Neural Development Impaired movement in patient fibroblasts suggests, but does not demonstrate, defective neuronal migration.

Show evidence (1 reference)

PMID:20305790 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Impaired beta1-integrin recycling affected cell motility, as reflected by changes in cell spreading and wound healing."

The primary fibroblast assay documents impaired motility.

Golgi Organization Defects

Mechanism confidence: Established

Patient fibroblasts and engineered human cell models exhibit fragmented Golgi. SNAP29-depleted HeLa cells show delayed ER-to-Golgi delivery of a reporter, with eventual arrival; this does not imply complete arrest of secretion.

Experimental models

SNAP29-depleted human neuroepithelial stem cells IPSC DERIVED MODEL Measures Golgi organization in a neural-lineage model.

Downstream

Abnormal Neural Development Golgi and secretory-pathway disturbances in neural-lineage cells may contribute to abnormal development.

Show evidence (1 reference)

PMID:33718375 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Correct GA morphology is restored upon ectopic expression of a functional RNAi-resistant GFP-tagged form of SNAP29"

The human-cell study directly tests Golgi structure and cargo transport.

Defective Mitotic Chromosome Segregation

Mechanism confidence: Provisional

SNAP29 depletion impairs kinetochore recruitment of KNL1 and ZWINT, stable microtubule attachment and chromosome segregation in human cell lines. Human neuroepithelial stem-cell knockdown also causes spindle abnormalities and micronuclei. These models identify a candidate developmental mechanism; they do not establish its contribution to each human brain malformation.

Experimental models

SNAP29-depleted human neuroepithelial stem cells IPSC DERIVED MODEL Measures micronuclear formation and spindle changes.

SNAP29 knockdown and rescue in HeLa and U2OS cells CELL LINE Tests kinetochore localization and mitotic phenotypes.

Downstream

Abnormal Neural Development Defective progenitor divisions could alter brain development; this has not been causally resolved in patients.

Show evidence (2 references)

PMID:27647876 SUPPORT DIRECT PRIMARY RESULT In Vitro

"KNL1 and ZWINT are not found at KTs in SNAP29 KD cells"

Loss of kinetochore localization occurs without a corresponding reduction in total protein.

PMID:33718375 SUPPORT DIRECT PRIMARY RESULT In Vitro

"SNAP29 KD NES cells often formed micronuclei, compared to mock-treated controls"

The human neuroepithelial model supplies a neural-lineage readout.

Abnormal Neural Development

Mechanism confidence: Provisional

SNAP29-related abnormalities of trafficking, mitosis and neuronal organization are candidate contributors to impaired brain development. Structural malformations are variable and can be absent. The relative contributions of migration, proliferation, neuronal survival and circuit formation remain unresolved.

Animal models

Mixed CD1/FvB Snap29 exon-2 knockouts Mus musculus fails to recapitulate Tests whether mutant mice reproduce human brain malformations.

Downstream

Polymicrogyria This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.

Corpus callosum hypoplasia This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.

Corpus callosum agenesis This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.

Global developmental delay This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.

Intellectual disability This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.

Optic nerve hypoplasia This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.

Poor head control Impaired neural development may contribute, although the specific intervening cellular pathway is unresolved.

Dysarthria Impaired neural development may contribute, although the specific intervening cellular pathway is unresolved.

Cerebral visual impairment Impaired neural development may contribute, although the specific intervening cellular pathway is unresolved.

Seizures Abnormal developing neural circuits may produce seizures; the contribution of individual malformations is unresolved.

Axial hypotonia Impaired central motor development may contribute to low axial tone.

Generalized hypotonia Central motor dysfunction may contribute alongside variable peripheral neuropathy.

Lower limb spasticity Abnormal central motor pathways may contribute to lower-limb spasticity; the specific lesion is unresolved.

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Typical radiographic findings of CEDNIK syndrome are dysgenesis of the corpus callosum and PMG."

Primary imaging establishes the structural outcome, not a specific cellular route.

Abnormal Cerebral Myelination

Mechanism confidence: Established

Hypomyelination is documented in four of six patients in the 2021 series. One patient had initially normal myelination followed by marked loss, showing that abnormal white matter can reflect progressive loss as well as impaired development. The responsible cell type and molecular steps remain uncertain.

Downstream

Cerebral hypomyelination Deficient cerebral myelin is visible on MRI.

Developmental regression Progressive myelin loss coincides with regression in one patient; causality remains provisional.

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"normal myelination at 14 months but loss of normal T1 hyperintense white matter signal at 12 years"

Serial MRI demonstrates acquired myelin loss in patient 1.

Context-Dependent Autophagic Clearance Disturbance

Mechanism confidence: Provisional

SNAP29 participates in autophagic membrane fusion, but loss does not produce an identical readout in every model. Zebrafish mutants accumulate LC3-II, p62 and abnormal multilamellar structures. Mouse fibroblast LC3-II elevation with unchanged p62 is compatible with increased autophagy induction; it does not prove a fusion block. Undifferentiated mouse ESCs retain low marker levels unless SNAP47 is also depleted.

Experimental models

Snap29-null primary mouse fibroblasts PRIMARY CELL CULTURE Measures static autophagy-marker changes.

Snap29-null mouse embryonic stem cells CELL LINE Tests dependence of autophagy markers on cell state and SNAP47.

Animal models

snap29 K164* and N171fs zebrafish Danio rerio measures Measures LC3/p62 accumulation and abnormal organelles.

Show evidence (2 references)

PMID:30718891 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We observed a mild increase in both LC3II and the autophagy adapter p62"

Whole-larva markers support altered clearance, without a direct fusion-flux measurement.

PMID:36614195 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Snap29 knockout or knockdown in mouse ESCs did not lead to the accumulation of the autophagosome marker LC3-II or the universal autophagic substrate SQSTM1/p62"

The negative finding limits a universal autophagy-block model.

Endoplasmic Reticulum Stress

Mechanism confidence: Provisional

Primary fibroblasts from Snap29-null mice show increased CHOP. ER stress could contribute to autophagy induction; the study does not establish that this is the mechanism of human neurological disease.

Experimental models

Snap29-null primary mouse fibroblasts PRIMARY CELL CULTURE Measures the CHOP stress response.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT PRIMARY RESULT In Vitro

"western blot analysis revealed a strong 5-fold induction of CHOP in mutant fibroblasts"

The readout is from cultured mouse fibroblasts, not a direct patient-tissue or epidermal measurement.

Altered Motor Neuron Organization

Mechanism confidence: Provisional

Zebrafish snap29 mutants lack selected trigeminal motor nuclei and display excessive motor-axon branching. These findings provide a model for neuromotor and feeding impairment, but do not prove a shared causal route for all human neurological manifestations.

Animal models

snap29 K164* and N171fs zebrafish Danio rerio partially recapitulates Models missing trigeminal motor nuclei and axonal hyperbranching.

Show evidence (1 reference)

PMID:30718891 SUPPORT DIRECT PRIMARY RESULT Model Organism

"These results suggest that Snap29 is required to ensure correct neuromuscular system development in zebrafish."

The mutant motor-neuron imaging establishes a vertebrate developmental phenotype.

Peripheral Nerve Myelin Dysfunction

Mechanism confidence: Provisional

Electrophysiology in one child showed markedly slowed conduction and absent sensory responses consistent with diffuse sensorimotor demyelinating polyneuropathy. The SNAP29-dependent cell biology responsible for this peripheral myelin phenotype is unresolved.

Downstream

Peripheral demyelination The electrophysiological myelin phenotype is clinically classified as peripheral demyelination.

Peripheral neuropathy The myelin defect contributes to sensorimotor neuropathy.

Areflexia Peripheral nerve dysfunction can impair the reflex arc; reflexes are variable across patients.

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"the electroneurographic study was confirmatory for the presence of diffuse sensorimotor demyelinating polyneuropathy."

The primary report documents this manifestation in a molecularly characterized patient or series.

Impaired Swallowing

Mechanism confidence: Established

Swallowing dysfunction with thin-liquid aspiration was documented in a confirmed patient. This can contribute to feeding difficulties, poor nutrition and aspiration-related respiratory morbidity; the exact neural or muscular defect is unresolved.

Downstream

Dysphagia Impaired swallowing manifests as dysphagia.

Feeding difficulties Unsafe swallowing requires feeding modifications.

Failure to thrive Feeding impairment can limit nutritional intake; other contributors may coexist.

Aspiration pneumonia Documented aspiration can contribute to pneumonia, which is a major complication in the clinical series.

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"A swallow study showed dysphagia and aspiration of thin liquids"

The primary report documents this manifestation in a molecularly characterized patient or series.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Cardiovascular 1

Supraventricular tachycardia HP:0004755

Show evidence (1 reference)

PMID:40709160 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"electrocardiography (ECG) revealed supraventricular tachycardia (SVT) with a heart rate of 280 beats per minute."

The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.

Digestive 4

Feeding difficulties HP:0011968

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At birth, patient 3 had difficulty feeding and received a G-tube at the age of 2 for failure to thrive."

The primary report documents this manifestation in a molecularly characterized patient or series.

Dysphagia HP:0002015

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"A swallow study showed dysphagia and aspiration of thin liquids"

The primary report documents this manifestation in a molecularly characterized patient or series.

Gastroesophageal reflux HP:0002020

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"During infancy, patient 5 had feeding difficulties, gastroesophageal reflux, failure to thrive, and recurrent respiratory tract infections leading to multiple hospitalizations."

The primary report documents this manifestation in a molecularly characterized patient or series.

Constipation HP:0002019

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She takes levothyroxine for hypothyroidism, gabapentin for spasticity, and laxatives for constipation."

The primary report documents this manifestation in a molecularly characterized patient or series.

Ear 1

Sensorineural hearing impairment HP:0000407

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Mild sensorineural deafness was demonstrated in three patients studied."

The primary report documents this manifestation in a molecularly characterized patient or series.

Endocrine 1

Precocious puberty HP:0000826

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She had premature thelarche with breast development at the age of 7, but menstruation began at the age of 9."

The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.

Eye 7

Optic nerve hypoplasia HP:0000609

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The intraconal optic nerves are hypoplastic"

The primary report documents this manifestation in a molecularly characterized patient or series.

Optic atrophy HP:0000648

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Ophthalmology assessment showed bilateral esotropia and optic atrophy."

The primary report documents this manifestation in a molecularly characterized patient or series.

Cerebral visual impairment HP:0100704

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She has global DD complicated by cortical visual impairment and profound sensorineural deafness."

The primary report documents this manifestation in a molecularly characterized patient or series.

Nystagmus HP:0000639

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Ophthalmologic examination showed nystagmus and foveal hypoplasia."

The primary report documents this manifestation in a molecularly characterized patient or series.

Strabismus HP:0000486

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She is hyperopic and required 3 corrective surgeries for strabismus."

The primary report documents this manifestation in a molecularly characterized patient or series.

Roving eye movements Abnormality of eye movement HP:0000496

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She is nonverbal and exhibits repetitive behaviors, purposeless movements, and roving eye movements."

The clinical description explicitly preserves the less specific movement label.

Hypertelorism HP:0000316

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"facial dysmorphism including elongated faces, antimongolian eye slant, slight hypertelorism, and flat broad nasal root."

The primary report documents this manifestation in a molecularly characterized patient or series.

Head and Neck 4

Progressive microcephaly HP:0000253

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"All patients had progressive microcephaly and facial dysmorphism"

The primary report documents this manifestation in a molecularly characterized patient or series.

Long face HP:0000276

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"facial dysmorphism including elongated faces, antimongolian eye slant, slight hypertelorism, and flat broad nasal root."

The primary report documents this manifestation in a molecularly characterized patient or series.

Downslanted palpebral fissures HP:0000494

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"facial dysmorphism including elongated faces, antimongolian eye slant, slight hypertelorism, and flat broad nasal root."

The primary report documents this manifestation in a molecularly characterized patient or series.

Synophrys HP:0000664

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"synophrys, hirsutism, low frontal hairline, bushy eyebrows, long eyelashes, deep-set eyes, large ears, and a bifid uvula"

The primary report documents this manifestation in a molecularly characterized patient or series.

Immune 1

Aspiration pneumonia HP:0011951

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Three male patients died of aspiration pneumonia between 5 and 12 years of age."

The primary report documents this manifestation in a molecularly characterized patient or series.

Integument 2

Ichthyosis HP:0008064

Show evidence (1 reference)

PMID:38590735 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At age of 10 years the patient developed fine scales on extremities, and progressive thickening of the toenails and soles."

The primary report documents this manifestation in a molecularly characterized patient or series.

Palmoplantar keratoderma Palmoplantar hyperkeratosis HP:0000972

Show evidence (1 reference)

PMID:35229899 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Palmoplantar keratoderma, reported as a cardinal sign in CEDNIK syndrome, was absent in both patients as of the last follow-up"

The primary report documents this manifestation in a molecularly characterized patient or series.

Musculoskeletal 6

Axial hypotonia HP:0008936

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"He has truncal hypotonia, poor limb movement, and tight Achilles tendons."

The primary report documents this manifestation in a molecularly characterized patient or series.

Generalized hypotonia HP:0001290

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Motor system manifestations included generalized hypotonia, weakness, and areflexia."

The primary report documents this manifestation in a molecularly characterized patient or series.

Poor head control HP:0002421

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Roving eye movements, poor head and trunk control, and failure to thrive were the presenting symptoms during the first 4 mo of life."

The founding infant histories establish the early motor finding.

Lower limb spasticity HP:0002061

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"increased muscle tone in his lower extremities with significant spasticity in his hamstrings and adductors"

The primary report documents this manifestation in a molecularly characterized patient or series.

Scoliosis HP:0002650

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At approximately 8 years, the patient was diagnosed with kyphoscoliosis and coxa valga."

The primary report documents this manifestation in a molecularly characterized patient or series.

Joint contractures HP:0034392

Show evidence (1 reference)

PMID:38590735 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"clubbing of the feet and contractures on distal joints"

The primary report documents this manifestation in a molecularly characterized patient or series.

Nervous System 13

Corpus callosum hypoplasia Hypoplasia of the corpus callosum HP:0002079

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Specifically, the splenium of the corpus callosum is hypoplastic"

The primary report documents this manifestation in a molecularly characterized patient or series.

Corpus callosum agenesis Agenesis of corpus callosum HP:0001274

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"typical absence of corpus callosum, in patient 5."

The founding MRI figure distinguishes absence from the broader dysgenesis spectrum.

Polymicrogyria HP:0002126

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"bilateral frontoparietal polymicrogyria with abnormal cortical folding"

The primary report documents this manifestation in a molecularly characterized patient or series.

Cerebral hypomyelination HP:0006808

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Four of 6 patients had white matter changes consistent with significantly decreased myelin content."

The primary report documents this manifestation in a molecularly characterized patient or series.

Context-specific annotations (1)

Six newly reported patients in the 2021 cohort FREQUENT

Four of six had marked white-matter myelin abnormalities; a fifth had subtler occipital hypomyelination. This is a small clinical series, not population penetrance.

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Four of 6 patients had white matter changes consistent with significantly decreased myelin content."

The primary report documents this manifestation in a molecularly characterized patient or series.

Peripheral neuropathy HP:0009830

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"there is clinical evidence for peripheral neuropathy and through electrophysiological study, demyelination of sensory, and motor nerves was confirmed."

The primary report documents this manifestation in a molecularly characterized patient or series.

Peripheral demyelination HP:0011096

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"the electroneurographic study was confirmatory for the presence of diffuse sensorimotor demyelinating polyneuropathy."

The primary report documents this manifestation in a molecularly characterized patient or series.

Areflexia HP:0001284

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Motor system manifestations included generalized hypotonia, weakness, and areflexia."

The primary report documents this manifestation in a molecularly characterized patient or series.

Seizures HP:0001250

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"He developed seizures at 4 months with multifocal epileptiform discharges on EEG, for which he took phenobarbitone until seizures resolved at the age of 2."

The primary report documents this manifestation in a molecularly characterized patient or series.

Global developmental delay HP:0001263

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"All patients exhibit DD, ichthyosis and/or palmoplantar keratoderma, and hypotonia."

The primary report documents this manifestation in a molecularly characterized patient or series.

Intellectual disability HP:0001249

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"including neurological impairment, brain malformation, global developmental delay/intellectual disability, optic nerve dysplasia, facial dysmorphism, palmoplantar keratoderma, and ichthyosis."

The molecularly confirmed case explicitly reports intellectual disability; a formal severity grade is not inferred.

Developmental regression HP:0002376

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She lost motor and speech milestones at the age of 12–13."

The primary report documents this manifestation in a molecularly characterized patient or series.

Dysarthria HP:0001260

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She knows few words, and her speech is dysarthric."

The primary report documents this manifestation in a molecularly characterized patient or series.

Tethered cord HP:0002144

Show evidence (1 reference)

PMID:40709160 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"a spinal magnetic resonance imaging (MRI) that revealed a tethered cord"

The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.

Growth 2

Failure to thrive HP:0001508

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At 18 months, patient 4 required a G-tube for feeding difficulties and poor weight gain."

The primary report documents this manifestation in a molecularly characterized patient or series.

Short stature HP:0004322

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"her height and weight were <1st and 11th percentile, respectively."

The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.

🧬

Genetic Associations

SNAP29

Gene: SNAP29 hgnc:11133 relationship_type: CAUSATIVE

Show evidence (3 references)

PMID:15968592 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Using homozygosity mapping in two large families, we localized the disease gene to 22q11.2"

The founding families establish recessive inheritance.

PMID:23231787 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"as is the case with the SNAP29 abnormalities observed in patients 1 and 2 and their features of CEDNIK syndrome"

The primary deletion series supports recessive unmasking in its two truncating-variant cases.

PMID:35093605 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The patient presents a combination of a loss-of-function SNAP29 mutation and a ∼370 kb 22q11.2 deletion, each of these genetic variants inherited from one of the parents."

A smaller deletion opposite a sequence allele is another documented configuration.

Variants (6)

c.223delG (p.Val75Serfs*28)

Founding frameshift, historically reported as c.220delG using a different numbering convention. Patient fibroblasts showed markedly reduced RNA and protein.

c.487dup (p.Ser163Lysfs*6)

Historically described as c.486insA or c.486_487insA. Transfection and organotypic assays support loss of function; truncated protein can be expressed and mislocalized.

c.2T>C start-loss

Homozygous in two siblings with relatively greater motor/language acquisition and compound heterozygous with c.354dupG in a skin-negative hypomyelinating presentation. Residual translation is hypothesized, not established.

c.622G>T (p.Glu208*)

Last-exon stop variant in one patient; escape from nonsense-mediated decay is predicted rather than experimentally demonstrated.

c.85C>T (p.Arg29*)

Homozygous in a molecularly confirmed patient; both parents were heterozygous. Nonsense-mediated decay or truncation was predicted.

Pathogenic sequence allele in trans with a SNAP29-containing deletion

Recessive unmasking can occur within 22q11.2 deletion syndrome or with a smaller deletion; additional deleted genes complicate phenotype attribution.

💊

Medical Actions

Emollient skin care

Action: Topical emollient therapy Ontology label: Pharmacotherapy NCIT:C15986

Platform: Other

Regular emollients were used for xerosis in a molecularly confirmed patient. Published CEDNIK-specific treatment evidence is descriptive.

Target Phenotypes: Ichthyosis HP:0008064

Show evidence (1 reference)

PMID:38590735 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The patient has diffuse xerosis and subtle erythema on extremities since birth, both managed with emollients."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Swallowing-directed feeding modification

Action: Swallowing-directed texture modification Ontology label: Dietary Intervention NCIT:C15447

Platform: Behavioral / lifestyle

Documented aspiration can prompt texture modification. In one confirmed patient, thin-liquid aspiration on swallow study led to thickened liquids.

Mechanism Target:

BYPASSES Impaired Swallowing — Texture modification adapts feeding to the demonstrated swallowing problem; it does not restore SNAP29.

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"he was fed only thickened liquids until 7 years."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Target Phenotypes: Dysphagia HP:0002015

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"he was fed only thickened liquids until 7 years."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Gastrostomy feeding

Action: Gastrostomy tube placement Ontology label: Surgical Procedure NCIT:C15329

Platform: Surgery

Gastrostomy can provide nutrition when feeding difficulties and poor growth warrant it; it does not by itself eliminate aspiration risk.

Target Phenotypes: Feeding difficulties HP:0011968 Failure to thrive HP:0001508

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At birth, patient 3 had difficulty feeding and received a G-tube at the age of 2 for failure to thrive."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Individualized antiseizure medication

Action: Anticonvulsant Therapy NCIT:C64172

Agent: phenobarbital CHEBI:8069

Platform: Small molecule

Treatment is selected for the individual seizure disorder. Phenobarbitone-associated seizure resolution is described in one child; no comparative CEDNIK regimen is established.

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"He developed seizures at 4 months with multifocal epileptiform discharges on EEG, for which he took phenobarbitone until seizures resolved at the age of 2."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Physical and occupational rehabilitation

Action: Rehabilitation NCIT:C15315

Platform: Behavioral / lifestyle

Therapy and mobility aids address functional limitations. One molecularly confirmed child used a wheelchair, walker, gait trainer and ankle-foot orthoses alongside therapy.

Target Phenotypes: Global developmental delay HP:0001263

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The patient is currently enrolled in third grade and receives physical and occupational and swimming therapy."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Augmentative communication

Action: Augmentative communication support Ontology label: Rehabilitation NCIT:C15315

Platform: Behavioral / lifestyle

Picture-board communication and individualized learning supports may assist individuals with limited speech.

Target Phenotypes: Global developmental delay HP:0001263

Show evidence (1 reference)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"including communication by picture board and understanding of simple learning games."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Corrective strabismus surgery

Action: Strabismus correction Ontology label: Surgical Procedure NCIT:C15329

Platform: Surgery

Ophthalmologic management includes corrective surgery when indicated; it does not correct optic-nerve or cerebral visual pathology.

Target Phenotypes: Strabismus HP:0000486

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She is hyperopic and required 3 corrective surgeries for strabismus."

The primary case records supportive care; it does not establish controlled treatment efficacy.

Symptomatic gastrointestinal treatment

Action: Symptomatic gastrointestinal pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986

Agent: omeprazole CHEBI:7772

Platform: Small molecule

Reflux and constipation are treated according to the individual problem. Omeprazole and laxatives are reported in affected children; these observations do not establish a syndrome-specific regimen.

Target Phenotypes: Gastroesophageal reflux HP:0002020 Constipation HP:0002019

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She takes omeprazole for gastroesophageal reflux"

The primary case records supportive care; it does not establish controlled treatment efficacy.

Genetic counseling

Action: Genetic Counseling NCIT:C15240

Counseling uses the confirmed variants and parental testing to explain recessive inheritance and family testing. A deletion on one allele requires attention to its extent and additional gene content.

Show evidence (1 reference)

PMID:35093605 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"each of these genetic variants inherited from one of the parents"

The documented segregation supports family-specific counseling.

🔬

Diagnosis

Molecular diagnosis

Sequence analysis of SNAP29, usually through exome or an appropriate panel, should be interpreted together with deletion/duplication assessment and parental segregation. Apparent homozygosity can reflect a variant opposite a deletion. Clinical suspicion is appropriate despite absent ichthyosis, keratoderma or polymicrogyria; uncertain missense predictions alone are insufficient to establish CEDNIK.

Show evidence (2 references)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Clinical exome or targeted sequencing were performed to elucidate the molecular genetic cause"

The cohort was molecularly characterized.

PMID:35093605 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"each of these genetic variants inherited from one of the parents"

Segregation demonstrated the sequence-variant/deletion configuration.

Brain MRI and longitudinal neurological assessment

MRI characterizes cortical, callosal and white-matter abnormalities. Serial imaging may distinguish impaired myelination from later loss when the clinical course changes; the existing series does not establish a universal scanning interval.

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Serial imaging in future patients could help determine which SNAP29 variants are associated with this pattern of white matter disease."

The authors propose longitudinal imaging to clarify variable white-matter disease.

Peripheral neurophysiology

Nerve-conduction studies and electromyography can characterize suspected neuropathy and distinguish demyelinating or neurogenic findings.

Show evidence (1 reference)

PMID:35359556 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"the electroneurographic study was confirmatory for the presence of diffuse sensorimotor demyelinating polyneuropathy."

Electrophysiology established the neuropathy subtype in this patient.

Swallowing, hearing and visual assessment

Clinical assessment is directed by feeding, hearing and visual difficulties. Swallow studies can detect aspiration; ophthalmologic and auditory evaluation distinguish optic-nerve, cortical, ocular and sensorineural abnormalities.

Show evidence (2 references)

PMID:29051910 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"A swallow study showed dysphagia and aspiration of thin liquids"

The primary case demonstrates an actionable swallowing finding.

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Ophthalmologic examination showed nystagmus and foveal hypoplasia."

Ophthalmology resolves specific visual findings.

📈

Progression

Infantile developmental presentation with variable skin onset

Poor head control, hypotonia and developmental delay often emerge in infancy. The founding skin manifestations appeared at 5–11 months; skin findings can appear much later or remain absent.

Show evidence (1 reference)

PMID:38590735 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At age of 10 years the patient developed fine scales on extremities, and progressive thickening of the toenails and soles."

The molecularly confirmed case developed the characteristic cutaneous findings late; onset is not uniformly neonatal.

Variable later neurological course

Some individuals acquire walking and speech, while others remain nonambulatory and nonverbal. Loss of acquired motor and speech skills and progressive myelin loss were documented in an adolescent. Survival to 19 years is reported; childhood aspiration-pneumonia deaths in the founding families do not establish a uniform survival limit.

Show evidence (2 references)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Patient 1 is a 19-year-old woman"

The cohort includes survival into adulthood.

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She lost motor and speech milestones at the age of 12–13."

The primary history demonstrates regression, not solely developmental delay.

📊

Prevalence

Published patients through the 2021 six-patient series

Cases In Literature Ultra Rare

The series added six patients from five families to 19 previously reported individuals. This is a literature count, not a population prevalence estimate; later case reports exist and some reports overlap.

Show evidence (1 reference)

PMID:33977139 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Here, we describe 6 additional patients with CEDNIK syndrome from 5 unrelated families"

The authors distinguish their new cohort from earlier reports.

🔀

Differential Diagnoses

Conditions with similar clinical presentations that must be differentiated from CEDNIK Syndrome:

Sjogren-Larsson syndrome MONDO:0010031

Overlapping Features Another neuroichthyotic disorder considered in the founding diagnostic workup.

Distinguishing Features

The founding series excluded overlapping metabolic disorders through biochemical evaluation; SNAP29 molecular findings establish CEDNIK.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader SUPPORT DIRECT PRIMARY RESULT Human Clinical

"a large number of syndromes with closely related clinical manifestations, including Sjogren Larsson syndrome"

The primary diagnostic workup explicitly considered this overlap.

MEDNIK syndrome MONDO:0012251

Overlapping Features A related disorder of intracellular trafficking with neurological and cutaneous overlap.

Distinguishing Features

MEDNIK is associated with AP1S1 rather than SNAP29; molecular testing resolves the etiologic distinction.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT BACKGROUND Human Clinical

"mutations in AP1S1 encoding a component of adaptor protein complex 1"

The mouse paper summarizes the established human trafficking-disorder differential.

🧫

Experimental Models

SNAP29-knockdown three-dimensional human keratinocyte organotypic culture OTHER

Primary human keratinocyte organotypic cultures reproduce epidermal histological abnormalities after SNAP29 downregulation.

Publication

PMID:21073448

Pathograph links

Abnormal Keratinocyte Differentiation partially recapitulates fidelity: moderate observes: cellular Models differentiation changes in human epidermal culture.

Limitations: Engineered knockdown rather than patient isogenic correction; full assessment is limited to the available abstract and later descriptions of the study.

Show evidence (1 reference)

PMID:21073448 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we could replicate histological features typical for CEDNIK syndrome in three-dimensional primary human keratinocyte organotypic cell cultures downregulated for SNAP29."

Human organotypic cultures reproduce histological features after SNAP29 knockdown.

CEDNIK patient-derived transformed fibroblasts CELL_LINE

Two transformed patient lines show delayed transferrin and integrin recycling, altered focal adhesions and reduced motility. Uptake and selected secretory/retrograde cargo assays were preserved.

Publication

PMID:20305790

Pathograph links

Impaired Endocytic Recycling partially recapitulates fidelity: moderate observes: cellular Measures patient-cell recycling kinetics.

Limitations: Nonisogenic transformed fibroblasts do not demonstrate neuronal migration.

Show evidence (1 reference)

PMID:20305790 SUPPORT DIRECT PRIMARY RESULT In Vitro

"During the chase times, disappearance of transferrin from CEDNIK cells was attenuated by 26–30% compared to control cells"

The patient-fibroblast study distinguishes recycling defects from preserved uptake and selected other trafficking routes.

Reduced Fibroblast Motility partially recapitulates fidelity: moderate observes: cellular Measures spreading and wound closure.

Limitations: A fibroblast migration readout is not a direct assay of cortical development.

Show evidence (1 reference)

PMID:20305790 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Impaired beta1-integrin recycling affected cell motility, as reflected by changes in cell spreading and wound healing."

The primary fibroblast assay documents impaired motility.

SNAP29-depleted human neuroepithelial stem cells IPSC_DERIVED_MODEL

Engineered knockdown in human iPSC-derived neuroepithelial stem cells produces Golgi fragmentation, spindle abnormalities and micronuclei.

Publication

PMID:33718375

Pathograph links

Golgi Organization Defects partially recapitulates fidelity: moderate observes: cellular Measures Golgi organization in a neural-lineage model.

Limitations: Cells were not derived from a CEDNIK patient; knockdown is not a biallelic patient variant.

Show evidence (1 reference)

PMID:33718375 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Depleted NES cells display GA fragmentation."

The figure directly documents the neural-lineage structural phenotype.

Defective Mitotic Chromosome Segregation partially recapitulates fidelity: moderate observes: cellular Measures micronuclear formation and spindle changes.

Limitations: Does not reproduce a complete developing cortex or establish the cause of polymicrogyria.

Show evidence (1 reference)

PMID:33718375 SUPPORT DIRECT PRIMARY RESULT In Vitro

"SNAP29 KD NES cells often formed micronuclei, compared to mock-treated controls"

The human neuroepithelial model supplies a neural-lineage readout.

SNAP29 knockdown and rescue in HeLa and U2OS cells CELL_LINE

Knockdown destabilizes kinetochore assembly and chromosome segregation; siRNA-resistant SNAP29 rescues selected mitotic readouts. The Q1Q2 trapping construct is an experimental mutant, not a human CEDNIK allele.

Publication

PMID:27647876

Pathograph links

Defective Mitotic Chromosome Segregation perturbs fidelity: moderate observes: cellular Tests kinetochore localization and mitotic phenotypes.

Limitations: Transformed non-neural cells and overexpression rescue limit disease-specific inference.

Show evidence (1 reference)

PMID:27647876 SUPPORT DIRECT PRIMARY RESULT In Vitro

"KNL1 and ZWINT are not found at KTs in SNAP29 KD cells"

Loss of kinetochore localization occurs without a corresponding reduction in total protein.

Snap29-null primary mouse fibroblasts PRIMARY_CELL_CULTURE

Basal and starvation immunoblots show increased LC3B-II, largely unchanged p62 and approximately fivefold CHOP induction.

Publication

PMID:26747696

Pathograph links

Endoplasmic Reticulum Stress measures fidelity: moderate observes: cellular Measures the CHOP stress response.

Limitations: Cultured mouse cells; static immunoblots do not establish a causal route to patient brain disease.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT PRIMARY RESULT In Vitro

"western blot analysis revealed a strong 5-fold induction of CHOP in mutant fibroblasts"

The readout is from cultured mouse fibroblasts, not a direct patient-tissue or epidermal measurement.

Context-Dependent Autophagic Clearance Disturbance measures fidelity: moderate observes: cellular Measures static autophagy-marker changes.

Limitations: No lysosomal-inhibitor turnover assay; the authors favor induction, potentially driven by ER stress.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT PRIMARY RESULT In Vitro

"p62/SQSTM1 protein amounts remained largely unchanged"

Unchanged p62 prevents interpretation of LC3-II accumulation as proof of blocked fusion.

Snap29-null mouse embryonic stem cells CELL_LINE

Two CRISPR clones and knockdown lines retain core pluripotency markers; differentiation is altered. Undifferentiated Snap29-null cells do not accumulate LC3-II/p62 unless Snap47 is also depleted.

Publication

PMID:36614195

Pathograph links

Context-Dependent Autophagic Clearance Disturbance fails to recapitulate fidelity: low observes: cellular Tests dependence of autophagy markers on cell state and SNAP47.

Limitations: The negative result applies to undifferentiated mouse ESCs with intact Snap47. Differentiation day seven and fourteen have different marker patterns; static levels do not measure flux directly.

Show evidence (1 reference)

PMID:36614195 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Snap29 knockout or knockdown in mouse ESCs did not lead to the accumulation of the autophagosome marker LC3-II or the universal autophagic substrate SQSTM1/p62"

The negative finding limits a universal autophagy-block model.

CRISPR SNAP29-null MRC5Vi fibroblast clone CELL_LINE

An engineered immortalized human fetal-lung fibroblast clone lacks detectable SNAP29 and has reduced growth. The study creates a model; it does not measure autophagic flux or validate a CEDNIK treatment.

Publication

PMID:34069872

Pathograph links

SNAP29 Loss of Function perturbs fidelity: low observes: cellular Removes detectable SNAP29 in a human cell line.

Limitations: One clone with persistent lentiviral Cas9; off-target or insertion effects and lack of isogenic rescue limit phenotype attribution.

Show evidence (1 reference)

PMID:34069872 SUPPORT DIRECT PRIMARY RESULT In Vitro

"By Western blot analyses no SNAP29 protein was detected in MRC5Vi SNAP29 KO cells"

The knockout model lacks detectable target protein.

🐁

Animal Models

C57BL/6 global and keratinocyte-specific Snap29 knockouts

Both lines develop severe congenital ichthyosis, acanthosis, hyperkeratosis, abnormal granules and neonatal lethality. Tissue-specific knockout demonstrates an epidermal requirement.

Species

Mus musculus

Genotype

Global Snap29 knockout or Snap29 floxed / K14-Cre epidermal knockout

Publication

PMID:26747696

Pathograph links

Lamellar Granule Maturation Failure partially recapitulates fidelity: moderate observes: cellular Models abnormal granules and reduced cargo secretion.

Limitations: Normal-appearing granules coexist with malformed structures; severity exceeds human skin disease.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT PRIMARY RESULT Model Organism

"The amount of secreted LB contents between SG and SC was strongly reduced in mutant epidermis"

Electron microscopy directly demonstrates diminished secretion.

Epidermal Barrier Impairment partially recapitulates fidelity: moderate observes: tissue Directly tests permeability and water loss.

Limitations: Neonatal barrier lethality and acanthosis are model-specific divergences from typical CEDNIK.

Show evidence (1 reference)

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content SUPPORT DIRECT PRIMARY RESULT Model Organism

"Both experiments indicate severe functional impairment of the epidermal barrier."

Dye intrusion and dehydration directly test the barrier in mutant mice.

Mixed CD1/FvB Snap29 exon-2 knockouts

Most mutants survive to adulthood. They show variable skin disease, gait and grip abnormalities and retinal defects. Male infertility is a mouse finding and is not established as a human CEDNIK feature.

Species

Mus musculus

Genotype

Two exon-2 deletion lines maintained on a mixed CD1/FvB background

Publication

PMID:31633066

Pathograph links

Epidermal Barrier Impairment fails to recapitulate fidelity: moderate observes: tissue Tests delayed prenatal barrier acquisition followed by normalization.

Limitations: A functional barrier exists at birth despite later skin changes, unlike the C57BL/6 model.

Show evidence (1 reference)

PMID:31633066 SUPPORT DIRECT PRIMARY RESULT Model Organism

"although skin barrier formation is delayed in homozygous mutant embryos, a proper skin barrier was present at birth."

The mixed-background model limits generalization of the neonatal barrier defect.

Abnormal Neural Development fails to recapitulate fidelity: moderate observes: tissue Tests whether mutant mice reproduce human brain malformations.

Limitations: Motor and retinal abnormalities occur without detectable cortical malformations; sporadic seizures were observed but not systematically quantified.

Show evidence (1 reference)

PMID:31633066 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we did not detect any morphological changes during neurogenesis or in adult brains"

The primary study explicitly reports the negative structural result.

snap29 K164* and N171fs zebrafish

Mutants develop microcephaly, early apoptotic-cell excess, neuromuscular disorganization, feeding failure and early death. K164* RNA is markedly reduced; the frameshift allele retains RNA. Transient GFP-snap29 expression improves selected phenotypes and prolongs survival without a durable adult rescue.

Species

Danio rerio

Genotype

ENU K164* and CRISPR frameshift alleles; detailed phenotyping chiefly K164*

Publication

PMID:30718891

Pathograph links

Altered Motor Neuron Organization partially recapitulates fidelity: moderate observes: tissue Models missing trigeminal motor nuclei and axonal hyperbranching.

Limitations: Larval zebrafish anatomy, feeding mechanics and developmental timing differ from humans.

Show evidence (1 reference)

PMID:30718891 SUPPORT DIRECT PRIMARY RESULT Model Organism

"These results suggest that Snap29 is required to ensure correct neuromuscular system development in zebrafish."

The mutant motor-neuron imaging establishes a vertebrate developmental phenotype.

Context-Dependent Autophagic Clearance Disturbance measures fidelity: moderate observes: cellular Measures LC3/p62 accumulation and abnormal organelles.

Limitations: Static markers and ultrastructure support disturbed clearance but do not directly measure fusion flux.

Show evidence (1 reference)

PMID:30718891 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We observed a mild increase in both LC3II and the autophagy adapter p62"

Whole-larva markers support altered clearance, without a direct fusion-flux measurement.

Abnormal Keratinocyte Differentiation fails to recapitulate fidelity: low observes: tissue Compares mutant epidermal organization with mammalian skin.

Limitations: Thinner periderm and lower keratin differ from human hyperkeratosis; larval fish skin has different layers.

Show evidence (1 reference)

PMID:30718891 SUPPORT DIRECT PRIMARY RESULT Model Organism

"mutants show a thinner peridermal layer composed of more elongated cells"

The thinner mutant periderm contrasts with human epidermal hyperkeratosis.

{ }

Source YAML

click to show

name: CEDNIK Syndrome
creation_date: "2026-09-17T14:55:00Z"
description: >-
  CEDNIK syndrome is an autosomal recessive SNAP29-related neurocutaneous disorder with variable developmental impairment, brain malformations, peripheral neuropathy, ichthyosis and palmoplantar keratoderma. Some molecularly confirmed individuals lack skin disease or cortical malformations. Loss of SNAP29 function disrupts selected membrane-trafficking pathways; patient skin demonstrates abnormal lamellar granules and retention of lipid and protease cargo. Cell models identify endocytic recycling, Golgi organization and mitotic defects, but the causal routes to human brain malformations remain incompletely resolved. Hypomyelination and later neurological regression broaden the disorder beyond a purely congenital malformation syndrome. Biallelic sequence variants or a pathogenic sequence variant opposite a deletion encompassing SNAP29 can cause disease; other deleted genes can contribute additional features.
synonyms:
- CEDNIK
- cerebral dysgenesis, neuropathy, ichthyosis and keratoderma syndrome
- cerebral dysgenesis-neuropathy-ichthyosis-keratoderma syndrome
- SNAP29 deficiency
- SNAP29-related disorder
category: Mendelian
disease_term:
  preferred_term: CEDNIK syndrome
  term:
    id: MONDO:0012290
    label: CEDNIK syndrome
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0012290
      label: CEDNIK syndrome
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
parents:
- autosomal recessive disease
- neurocutaneous syndrome
- rare disease
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Autosomal recessive inheritance with homozygous or compound heterozygous pathogenic SNAP29 variants. Two sequence variants can occur in trans, or a sequence variant can be paired with a deletion encompassing SNAP29. Carrier parents are generally unaffected; feature-specific variability does not demonstrate incomplete penetrance of the entire recessive disorder.
  evidence:
  - reference: PMID:15968592
    reference_title: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Using homozygosity mapping in two large families, we localized the disease gene to 22q11.2
    explanation: The founding families establish recessive inheritance.
  - reference: PMID:31748968
    reference_title: Compound heterozygous mutations in SNAP29 is associated with Pelizaeus-Merzbacher-like disorder (PMLD).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Exome sequencing in the trio revealed novel compound heterozygous pathogenic mutations in SNAP29 (p.Leu119AlafsX15, c.354DupG and p.0?, c.2T > C).
    explanation: The molecularly confirmed case demonstrates two different sequence alleles; the variant details are provided in the available abstract.
prevalence:
- population: Published patients through the 2021 six-patient series
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: The series added six patients from five families to 19 previously reported individuals. This is a literature count, not a population prevalence estimate; later case reports exist and some reports overlap.
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Here, we describe 6 additional patients with CEDNIK syndrome from 5 unrelated families
    explanation: The authors distinguish their new cohort from earlier reports.
progression:
- phase: Infantile developmental presentation with variable skin onset
  notes: Poor head control, hypotonia and developmental delay often emerge in infancy. The founding skin manifestations appeared at 5–11 months; skin findings can appear much later or remain absent.
  evidence:
  - reference: PMID:38590735
    reference_title: Keratoderma and ichthyosis as valuable features for the diagnosis of CEDNIK syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At age of 10 years the patient developed fine scales on extremities, and progressive thickening of the toenails and soles.
    explanation: The molecularly confirmed case developed the characteristic cutaneous findings late; onset is not uniformly neonatal.
- phase: Variable later neurological course
  notes: Some individuals acquire walking and speech, while others remain nonambulatory and nonverbal. Loss of acquired motor and speech skills and progressive myelin loss were documented in an adolescent. Survival to 19 years is reported; childhood aspiration-pneumonia deaths in the founding families do not establish a uniform survival limit.
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Patient 1 is a 19-year-old woman
    explanation: The cohort includes survival into adulthood.
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She lost motor and speech milestones at the age of 12–13.
    explanation: The primary history demonstrates regression, not solely developmental delay.
pathophysiology:
- name: SNAP29 Loss of Function
  description: 'Biallelic pathogenic variants reduce functional SNAP29. Protein abundance and localization depend on the allele: the founding deletion reduced RNA and protein, whereas the Ser163 frameshift can produce a truncated, mislocalized protein. Residual translation from the c.2T>C start-loss allele and nonsense-mediated-decay escape of p.Glu208* remain predictions.'
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:15968592
    reference_title: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: SNAP29 expression was decreased in the skin of the patients
    explanation: The founding allele reduces expression in patient tissue.
  - reference: PMID:21073448
    reference_title: CEDNIK syndrome results from loss-of-function mutations in SNAP29.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: In vitro transfection experiments indicated that this mutation results in SNAP29 loss-of-function.
    explanation: The second family allele was tested by transfection.
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: BACKGROUND
    directness: DIRECT
    snippet: Cell culture experiments suggest that the mutated protein is produced at normal levels with abnormal localization.
    explanation: The cohort cites the earlier Ser163 frameshift experiments; this is experimental background, not a new protein assay in the cohort.
  role: initiator
  genes:
  - preferred_term: SNAP29
    term:
      id: hgnc:11133
      label: SNAP29
  genetic_context:
    variant_origin: GERMLINE
    functional_impact_category: LOSS_OF_FUNCTION
  downstream:
  - target: Lamellar Granule Maturation Failure
    description: Reduced SNAP29 expression in patient skin is associated with abnormal granule maturation and cargo retention.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Impaired Endocytic Recycling
    description: Loss of SNAP29 in patient fibroblasts impairs transferrin and integrin recycling; initial uptake is preserved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Golgi Organization Defects
    description: SNAP29 depletion disrupts Golgi organization, with restoration after RNAi-resistant SNAP29 expression in human cells.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Defective Mitotic Chromosome Segregation
    description: SNAP29 depletion interferes with kinetochore assembly and chromosome segregation in human cell models.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Abnormal Cerebral Myelination
    description: Biallelic variants are associated with hypomyelination or later myelin loss; the responsible cellular pathway remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Context-Dependent Autophagic Clearance Disturbance
    description: SNAP29 loss perturbs autophagy-marker and organelle readouts in some models, with dependence on cell state and paralog compensation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Endoplasmic Reticulum Stress
    description: Snap29-null primary mouse fibroblasts show increased CHOP, providing a model-specific stress response.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Altered Motor Neuron Organization
    description: Zebrafish snap29 mutation alters trigeminal motor nuclei and axon branching; applicability to individual human manifestations is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Peripheral Nerve Myelin Dysfunction
    description: Biallelic SNAP29 dysfunction is associated with peripheral demyelinating neuropathy; the intervening cellular pathway is unknown.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Impaired Swallowing
    description: Neurological dysfunction can impair swallowing; the precise tissue and molecular contributors are unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Lamellar Granule Maturation Failure
  description: Patient epidermis contains abnormal clear vesicles alongside residual normal lamellar granules. Defective maturation and secretion mislocalize lipid and protease cargo; the defect is not complete absence of all granules.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:15968592
    reference_title: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: abnormal maturation of lamellar granules and, as a consequence, in mislocation of epidermal lipids and proteases.
    explanation: Patient skin directly supports disturbed granule maturation and cargo delivery.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  cellular_components:
  - preferred_term: epidermal lamellar body
    term:
      id: GO:0097209
      label: epidermal lamellar body
    modifier: ABNORMAL
  downstream:
  - target: Reduced Extracellular Epidermal Lipid Delivery
    description: Abnormal granules fail to deliver lipid cargo normally.
    causal_link_type: DIRECT
  - target: Epidermal Protease Cargo Retention
    description: Abnormal granules retain protease cargo.
    causal_link_type: DIRECT
  - target: Abnormal Keratinocyte Differentiation
    description: Disrupted granule function contributes to abnormal epidermal maturation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Extracellular Epidermal Lipid Delivery
  description: Glucosylceramides are retained within abnormal intracellular compartments rather than being delivered normally to the extracellular stratum corneum. This compromises the lipid lamellae that contribute to the permeability barrier.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: In the skin of our patients, considerable amounts of glucosylceramides were retained, abnormally, within the cells of lower stratum corneum
    explanation: The founding patient-skin immunoelectron microscopy localizes lipid cargo abnormally.
  downstream:
  - target: Epidermal Barrier Impairment
    description: Reduced delivery disrupts extracellular barrier lipids.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Epidermal Protease Cargo Retention
  description: Patient corneocytes retain KLK5 and KLK7 in abnormal vesicles. Reduced extracellular delivery limits the proteolysis needed for normal shedding of corneocytes.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Abnormal vesicles in the cornified cells were also found to contain KLK5 and KLK7, two proteases of major importance for normal desquamation
    explanation: Patient-skin localization identifies the affected protease cargo.
  downstream:
  - target: Impaired Corneocyte Desquamation
    description: Reduced extracellular protease availability impairs corneodesmosome degradation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Impaired Corneocyte Desquamation
  description: Defective delivery of lamellar-granule proteases provides a route to impaired corneodesmosome degradation and retention hyperkeratosis. Corneodesmosin remnants are demonstrated in SNAP29-deficient model epidermis.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: INDIRECT
    snippet: These findings indicate a delay in degradation of Cdsn due to reduced amounts of kallikrein 7.
    explanation: The mouse study connects reduced protease availability with retained corneodesmosin; translation to patient desquamation is supported by the shared cargo defect.
  downstream:
  - target: Ichthyosis
    description: Retention of corneocytes contributes to scaling.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Palmoplantar keratoderma
    description: Impaired shedding contributes to palmoplantar thickening.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Epidermal Barrier Impairment
  description: Abnormal extracellular lipid organization impairs skin-barrier function. Direct dye-permeability and dehydration assays show a severe defect in the C57BL/6 keratinocyte knockout; the mixed-background mouse instead establishes a functional barrier by birth.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Both experiments indicate severe functional impairment of the epidermal barrier.
    explanation: Dye intrusion and dehydration directly test the barrier in mutant mice.
  - reference: PMID:31633066
    reference_title: Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: although skin barrier formation is delayed in homozygous mutant embryos, a proper skin barrier was present at birth.
    explanation: The mixed-background model limits generalization of the neonatal barrier defect.
  biological_processes:
  - preferred_term: establishment of skin barrier
    term:
      id: GO:0061436
      label: establishment of skin barrier
    modifier: DECREASED
  downstream:
  - target: Ichthyosis
    description: Barrier impairment contributes to the ichthyotic phenotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Abnormal Keratinocyte Differentiation
  description: SNAP29 depletion alters epidermal differentiation in human organotypic cultures and mouse epidermis. The mouse phenotype includes abnormal differentiation-marker distribution and hyperproliferation; its acanthosis and neonatal lethality exceed the typical human skin phenotype.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:21073448
    reference_title: CEDNIK syndrome results from loss-of-function mutations in SNAP29.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we could replicate histological features typical for CEDNIK syndrome in three-dimensional primary human keratinocyte organotypic cell cultures downregulated for SNAP29.
    explanation: Human organotypic cultures reproduce histological features after SNAP29 knockdown.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: keratinocyte differentiation
    term:
      id: GO:0030216
      label: keratinocyte differentiation
    modifier: ABNORMAL
  downstream:
  - target: Ichthyosis
    description: Abnormal cornification contributes to scaling.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Palmoplantar keratoderma
    description: Abnormal cornification contributes to keratoderma.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Impaired Endocytic Recycling
  description: Two transformed patient fibroblast lines show delayed transferrin and beta-1-integrin recycling, enlarged early/recycling endosomes and abnormal focal-adhesion distribution. Transferrin uptake, VSVG secretory transport and cholera-toxin-B retrograde transport were preserved in these assays.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:20305790
    reference_title: Loss of SNAP29 impairs endocytic recycling and cell motility.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: During the chase times, disappearance of transferrin from CEDNIK cells was attenuated by 26–30% compared to control cells
    explanation: The patient-fibroblast study distinguishes recycling defects from preserved uptake and selected other trafficking routes.
  downstream:
  - target: Reduced Fibroblast Motility
    description: Defective integrin recycling can impair focal-adhesion turnover and cell movement.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Fibroblast Motility
  description: Patient fibroblasts show delayed spreading and wound closure in association with altered integrin recycling and focal adhesions. Extension to neuronal migration is a hypothesis, not a direct measurement in patient brain.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:20305790
    reference_title: Loss of SNAP29 impairs endocytic recycling and cell motility.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Impaired beta1-integrin recycling affected cell motility, as reflected by changes in cell spreading and wound healing.
    explanation: The primary fibroblast assay documents impaired motility.
  downstream:
  - target: Abnormal Neural Development
    description: Impaired movement in patient fibroblasts suggests, but does not demonstrate, defective neuronal migration.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Golgi Organization Defects
  description: Patient fibroblasts and engineered human cell models exhibit fragmented Golgi. SNAP29-depleted HeLa cells show delayed ER-to-Golgi delivery of a reporter, with eventual arrival; this does not imply complete arrest of secretion.
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:33718375
    reference_title: Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Correct GA morphology is restored upon ectopic expression of a functional RNAi-resistant GFP-tagged form of SNAP29
    explanation: The human-cell study directly tests Golgi structure and cargo transport.
  downstream:
  - target: Abnormal Neural Development
    description: Golgi and secretory-pathway disturbances in neural-lineage cells may contribute to abnormal development.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Defective Mitotic Chromosome Segregation
  description: SNAP29 depletion impairs kinetochore recruitment of KNL1 and ZWINT, stable microtubule attachment and chromosome segregation in human cell lines. Human neuroepithelial stem-cell knockdown also causes spindle abnormalities and micronuclei. These models identify a candidate developmental mechanism; they do not establish its contribution to each human brain malformation.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:27647876
    reference_title: An essential step of kinetochore formation controlled by the SNARE protein Snap29.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: KNL1 and ZWINT are not found at KTs in SNAP29 KD cells
    explanation: Loss of kinetochore localization occurs without a corresponding reduction in total protein.
  - reference: PMID:33718375
    reference_title: Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: SNAP29 KD NES cells often formed micronuclei, compared to mock-treated controls
    explanation: The human neuroepithelial model supplies a neural-lineage readout.
  downstream:
  - target: Abnormal Neural Development
    description: Defective progenitor divisions could alter brain development; this has not been causally resolved in patients.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Abnormal Neural Development
  description: SNAP29-related abnormalities of trafficking, mitosis and neuronal organization are candidate contributors to impaired brain development. Structural malformations are variable and can be absent. The relative contributions of migration, proliferation, neuronal survival and circuit formation remain unresolved.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Typical radiographic findings of CEDNIK syndrome are dysgenesis of the corpus callosum and PMG.
    explanation: Primary imaging establishes the structural outcome, not a specific cellular route.
  downstream:
  - target: Polymicrogyria
    description: This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Corpus callosum hypoplasia
    description: This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Corpus callosum agenesis
    description: This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Global developmental delay
    description: This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Intellectual disability
    description: This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Optic nerve hypoplasia
    description: This manifestation belongs to the documented developmental spectrum; the intervening cellular route is incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Poor head control
    description: Impaired neural development may contribute, although the specific intervening cellular pathway is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Dysarthria
    description: Impaired neural development may contribute, although the specific intervening cellular pathway is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Cerebral visual impairment
    description: Impaired neural development may contribute, although the specific intervening cellular pathway is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Seizures
    description: Abnormal developing neural circuits may produce seizures; the contribution of individual malformations is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Axial hypotonia
    description: Impaired central motor development may contribute to low axial tone.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Generalized hypotonia
    description: Central motor dysfunction may contribute alongside variable peripheral neuropathy.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Lower limb spasticity
    description: Abnormal central motor pathways may contribute to lower-limb spasticity; the specific lesion is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Abnormal Cerebral Myelination
  description: Hypomyelination is documented in four of six patients in the 2021 series. One patient had initially normal myelination followed by marked loss, showing that abnormal white matter can reflect progressive loss as well as impaired development. The responsible cell type and molecular steps remain uncertain.
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: normal myelination at 14 months but loss of normal T1 hyperintense white matter signal at 12 years
    explanation: Serial MRI demonstrates acquired myelin loss in patient 1.
  downstream:
  - target: Cerebral hypomyelination
    description: Deficient cerebral myelin is visible on MRI.
    causal_link_type: DIRECT
  - target: Developmental regression
    description: Progressive myelin loss coincides with regression in one patient; causality remains provisional.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Context-Dependent Autophagic Clearance Disturbance
  description: SNAP29 participates in autophagic membrane fusion, but loss does not produce an identical readout in every model. Zebrafish mutants accumulate LC3-II, p62 and abnormal multilamellar structures. Mouse fibroblast LC3-II elevation with unchanged p62 is compatible with increased autophagy induction; it does not prove a fusion block. Undifferentiated mouse ESCs retain low marker levels unless SNAP47 is also depleted.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:30718891
    reference_title: A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We observed a mild increase in both LC3II and the autophagy adapter p62
    explanation: Whole-larva markers support altered clearance, without a direct fusion-flux measurement.
  - reference: PMID:36614195
    reference_title: Snap29 Is Dispensable for Self-Renewal Maintenance but Required for Proper Differentiation of Mouse Embryonic Stem Cells.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Snap29 knockout or knockdown in mouse ESCs did not lead to the accumulation of the autophagosome marker LC3-II or the universal autophagic substrate SQSTM1/p62
    explanation: The negative finding limits a universal autophagy-block model.
- name: Endoplasmic Reticulum Stress
  description: Primary fibroblasts from Snap29-null mice show increased CHOP. ER stress could contribute to autophagy induction; the study does not establish that this is the mechanism of human neurological disease.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: western blot analysis revealed a strong 5-fold induction of CHOP in mutant fibroblasts
    explanation: The readout is from cultured mouse fibroblasts, not a direct patient-tissue or epidermal measurement.
- name: Altered Motor Neuron Organization
  description: Zebrafish snap29 mutants lack selected trigeminal motor nuclei and display excessive motor-axon branching. These findings provide a model for neuromotor and feeding impairment, but do not prove a shared causal route for all human neurological manifestations.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:30718891
    reference_title: A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: These results suggest that Snap29 is required to ensure correct neuromuscular system development in zebrafish.
    explanation: The mutant motor-neuron imaging establishes a vertebrate developmental phenotype.
- name: Peripheral Nerve Myelin Dysfunction
  description: Electrophysiology in one child showed markedly slowed conduction and absent sensory responses consistent with diffuse sensorimotor demyelinating polyneuropathy. The SNAP29-dependent cell biology responsible for this peripheral myelin phenotype is unresolved.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the electroneurographic study was confirmatory for the presence of diffuse sensorimotor demyelinating polyneuropathy.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
  downstream:
  - target: Peripheral demyelination
    description: The electrophysiological myelin phenotype is clinically classified as peripheral demyelination.
    causal_link_type: DIRECT
  - target: Peripheral neuropathy
    description: The myelin defect contributes to sensorimotor neuropathy.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Areflexia
    description: Peripheral nerve dysfunction can impair the reflex arc; reflexes are variable across patients.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Impaired Swallowing
  description: Swallowing dysfunction with thin-liquid aspiration was documented in a confirmed patient. This can contribute to feeding difficulties, poor nutrition and aspiration-related respiratory morbidity; the exact neural or muscular defect is unresolved.
  biological_scale: ORGANISM
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: A swallow study showed dysphagia and aspiration of thin liquids
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
  downstream:
  - target: Dysphagia
    description: Impaired swallowing manifests as dysphagia.
    causal_link_type: DIRECT
  - target: Feeding difficulties
    description: Unsafe swallowing requires feeding modifications.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Failure to thrive
    description: Feeding impairment can limit nutritional intake; other contributors may coexist.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Aspiration pneumonia
    description: Documented aspiration can contribute to pneumonia, which is a major complication in the clinical series.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
phenotypes:
- name: Ichthyosis
  description: Scaling is characteristic but not obligatory. Onset ranged from 5–11 months in the founding families to age ten years in a later case; molecularly confirmed skin-negative presentations exist.
  phenotype_term:
    preferred_term: Ichthyosis
    term:
      id: HP:0008064
      label: Ichthyosis
  evidence:
  - reference: PMID:38590735
    reference_title: Keratoderma and ichthyosis as valuable features for the diagnosis of CEDNIK syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At age of 10 years the patient developed fine scales on extremities, and progressive thickening of the toenails and soles.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Palmoplantar keratoderma
  description: Palmar and/or plantar thickening is variable and may emerge later. Its absence does not exclude SNAP29-related disease.
  phenotype_term:
    preferred_term: Palmoplantar hyperkeratosis
    term:
      id: HP:0000972
      label: Palmoplantar hyperkeratosis
  evidence:
  - reference: PMID:35229899
    reference_title: CEDNIK syndrome with phenotypic variability.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Palmoplantar keratoderma, reported as a cardinal sign in CEDNIK syndrome, was absent in both patients as of the last follow-up
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Corpus callosum hypoplasia
  description: The corpus callosum, particularly its splenium, may be hypoplastic. This is distinct from complete agenesis.
  phenotype_term:
    preferred_term: Hypoplasia of the corpus callosum
    term:
      id: HP:0002079
      label: Hypoplasia of the corpus callosum
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Specifically, the splenium of the corpus callosum is hypoplastic
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Corpus callosum agenesis
  description: Complete absence was illustrated in the founding series; it is not the correct binding for every callosal abnormality.
  phenotype_term:
    preferred_term: Agenesis of corpus callosum
    term:
      id: HP:0001274
      label: Agenesis of corpus callosum
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: typical absence of corpus callosum, in patient 5.
    explanation: The founding MRI figure distinguishes absence from the broader dysgenesis spectrum.
- name: Polymicrogyria
  description: Bilateral cortical polymicrogyria occurs in some patients, including frontoparietal or perisylvian distributions, but is absent in others.
  phenotype_term:
    preferred_term: Polymicrogyria
    term:
      id: HP:0002126
      label: Polymicrogyria
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: bilateral frontoparietal polymicrogyria with abnormal cortical folding
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Cerebral hypomyelination
  description: MRI can show reduced supratentorial myelin. Serial imaging in one patient demonstrates later myelin loss after an initially near-normal scan.
  phenotype_term:
    preferred_term: Cerebral hypomyelination
    term:
      id: HP:0006808
      label: Cerebral hypomyelination
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Four of 6 patients had white matter changes consistent with significantly decreased myelin content.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
  phenotype_contexts:
  - population: Six newly reported patients in the 2021 cohort
    frequency: FREQUENT
    notes: Four of six had marked white-matter myelin abnormalities; a fifth had subtler occipital hypomyelination. This is a small clinical series, not population penetrance.
    evidence:
    - reference: PMID:33977139
      reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Four of 6 patients had white matter changes consistent with significantly decreased myelin content.
      explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Peripheral neuropathy
  description: Peripheral neuropathy varies across affected individuals. Neurogenic muscle findings and abnormal nerve-conduction studies support peripheral involvement.
  phenotype_term:
    preferred_term: Peripheral neuropathy
    term:
      id: HP:0009830
      label: Peripheral neuropathy
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: there is clinical evidence for peripheral neuropathy and through electrophysiological study, demyelination of sensory, and motor nerves was confirmed.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Peripheral demyelination
  description: Diffuse sensorimotor demyelinating polyneuropathy was electrophysiologically characterized in one child. This subtype should not be assigned automatically to all reported neuropathy.
  phenotype_term:
    preferred_term: Peripheral demyelination
    term:
      id: HP:0011096
      label: Peripheral demyelination
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the electroneurographic study was confirmatory for the presence of diffuse sensorimotor demyelinating polyneuropathy.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Areflexia
  description: Absent tendon reflexes occur with peripheral neurological involvement; other patients have preserved or brisk reflexes.
  phenotype_term:
    preferred_term: Areflexia
    term:
      id: HP:0001284
      label: Areflexia
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Motor system manifestations included generalized hypotonia, weakness, and areflexia.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Seizures
  description: Seizures have variable onset and course; some patients respond to antiseizure medication and others never develop epilepsy.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: He developed seizures at 4 months with multifocal epileptiform discharges on EEG, for which he took phenobarbitone until seizures resolved at the age of 2.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Global developmental delay
  description: Motor and language development are delayed, with severity ranging from profound impairment to acquisition of walking, running and short sentences.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: All patients exhibit DD, ichthyosis and/or palmoplantar keratoderma, and hypotonia.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Intellectual disability
  description: Intellectual disability is reported alongside motor and language delay. Severity is variable, and formal testing is not available for every published patient.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: including neurological impairment, brain malformation, global developmental delay/intellectual disability, optic nerve dysplasia, facial dysmorphism, palmoplantar keratoderma, and ichthyosis.
    explanation: The molecularly confirmed case explicitly reports intellectual disability; a formal severity grade is not inferred.
- name: Axial hypotonia
  description: Truncal hypotonia and poor head control occur, sometimes with increased limb tone.
  phenotype_term:
    preferred_term: Axial hypotonia
    term:
      id: HP:0008936
      label: Axial hypotonia
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: He has truncal hypotonia, poor limb movement, and tight Achilles tendons.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Generalized hypotonia
  description: Some patients have generalized hypotonia rather than only axial involvement.
  phenotype_term:
    preferred_term: Generalized hypotonia
    term:
      id: HP:0001290
      label: Generalized hypotonia
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Motor system manifestations included generalized hypotonia, weakness, and areflexia.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Poor head control
  description: Poor head and trunk control are early manifestations in the founding families.
  phenotype_term:
    preferred_term: Poor head control
    term:
      id: HP:0002421
      label: Poor head control
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Roving eye movements, poor head and trunk control, and failure to thrive were the presenting symptoms during the first 4 mo of life.
    explanation: The founding infant histories establish the early motor finding.
- name: Progressive microcephaly
  description: Progressive microcephaly was present in the founding families and occurs in later cases; other molecularly confirmed patients retain a normal head circumference.
  phenotype_term:
    preferred_term: Progressive microcephaly
    term:
      id: HP:0000253
      label: Progressive microcephaly
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: All patients had progressive microcephaly and facial dysmorphism
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Developmental regression
  description: Loss of motor and speech milestones occurred at age twelve to thirteen in one patient. The course is not uniformly static.
  phenotype_term:
    preferred_term: Developmental regression
    term:
      id: HP:0002376
      label: Developmental regression
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She lost motor and speech milestones at the age of 12–13.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Lower limb spasticity
  description: Lower-limb spasticity can coexist with truncal hypotonia and contribute to gait impairment.
  phenotype_term:
    preferred_term: Lower limb spasticity
    term:
      id: HP:0002061
      label: Lower limb spasticity
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: increased muscle tone in his lower extremities with significant spasticity in his hamstrings and adductors
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Dysarthria
  description: Dysarthria can affect individuals who develop speech.
  phenotype_term:
    preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She knows few words, and her speech is dysarthric.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Optic nerve hypoplasia
  description: Hypoplastic optic nerves or discs contribute to visual impairment; they are distinct from cortical visual dysfunction.
  phenotype_term:
    preferred_term: Optic nerve hypoplasia
    term:
      id: HP:0000609
      label: Optic nerve hypoplasia
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The intraconal optic nerves are hypoplastic
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Optic atrophy
  description: Optic atrophy has also been reported.
  phenotype_term:
    preferred_term: Optic atrophy
    term:
      id: HP:0000648
      label: Optic atrophy
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Ophthalmology assessment showed bilateral esotropia and optic atrophy.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Cerebral visual impairment
  description: Cortical visual impairment can add to developmental limitations.
  phenotype_term:
    preferred_term: Cerebral visual impairment
    term:
      id: HP:0100704
      label: Cerebral visual impairment
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She has global DD complicated by cortical visual impairment and profound sensorineural deafness.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Nystagmus
  description: Nystagmus is documented in addition to less specifically characterized roving eye movements.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Ophthalmologic examination showed nystagmus and foveal hypoplasia.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Strabismus
  description: Strabismus is frequent in reported series, and some patients undergo corrective surgery.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She is hyperopic and required 3 corrective surgeries for strabismus.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- category: Ophthalmologic
  name: Roving eye movements
  description: >-
    Roving eye movements may appear early and also occur in older affected children; they are not equated with a specified nystagmus waveform.
  phenotype_term:
    preferred_term: Roving eye movements during infancy
    term:
      id: HP:0000496
      label: Abnormality of eye movement
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She is nonverbal and exhibits repetitive behaviors, purposeless movements, and roving eye movements.
    explanation: The clinical description explicitly preserves the less specific movement label.
- name: Sensorineural hearing impairment
  description: Sensorineural hearing loss ranges from mild to profound and is not obligatory. The founding report tested three affected children; later cases include bilateral or profound loss.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Mild sensorineural deafness was demonstrated in three patients studied.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Feeding difficulties
  description: Feeding impairment can require gastrostomy; some affected individuals eat orally but have poor weight gain.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At birth, patient 3 had difficulty feeding and received a G-tube at the age of 2 for failure to thrive.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Dysphagia
  description: Swallowing dysfunction can cause aspiration and require feeding modification.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: A swallow study showed dysphagia and aspiration of thin liquids
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Failure to thrive
  description: Poor weight gain may accompany feeding impairment and neurological disability. It is not assigned solely to water loss through the skin.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At 18 months, patient 4 required a G-tube for feeding difficulties and poor weight gain.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Gastroesophageal reflux
  description: Reflux is reported among gastrointestinal manifestations.
  phenotype_term:
    preferred_term: Gastroesophageal reflux
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: During infancy, patient 5 had feeding difficulties, gastroesophageal reflux, failure to thrive, and recurrent respiratory tract infections leading to multiple hospitalizations.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Constipation
  description: Constipation may require laxative treatment.
  phenotype_term:
    preferred_term: Constipation
    term:
      id: HP:0002019
      label: Constipation
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She takes levothyroxine for hypothyroidism, gabapentin for spasticity, and laxatives for constipation.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Aspiration pneumonia
  description: Aspiration pneumonia causes important morbidity and contributed to deaths in the founding series.
  phenotype_term:
    preferred_term: Aspiration pneumonia
    term:
      id: HP:0011951
      label: Aspiration pneumonia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Three male patients died of aspiration pneumonia between 5 and 12 years of age.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Scoliosis
  description: Scoliosis or kyphoscoliosis can develop during childhood.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At approximately 8 years, the patient was diagnosed with kyphoscoliosis and coxa valga.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Joint contractures
  description: Distal joint contractures were described in a thirteen-year-old patient; population frequency is unknown.
  phenotype_term:
    preferred_term: Joint contracture
    term:
      id: HP:0034392
      label: Joint contracture
  evidence:
  - reference: PMID:38590735
    reference_title: Keratoderma and ichthyosis as valuable features for the diagnosis of CEDNIK syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: clubbing of the feet and contractures on distal joints
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Long face
  description: This feature was described in the founding families; later cases do not share a uniform facial appearance.
  phenotype_term:
    preferred_term: Long face
    term:
      id: HP:0000276
      label: Long face
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: facial dysmorphism including elongated faces, antimongolian eye slant, slight hypertelorism, and flat broad nasal root.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Hypertelorism
  description: This feature was described in the founding families; later cases do not share a uniform facial appearance.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: facial dysmorphism including elongated faces, antimongolian eye slant, slight hypertelorism, and flat broad nasal root.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Downslanted palpebral fissures
  description: This feature was described in the founding families; later cases do not share a uniform facial appearance.
  phenotype_term:
    preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: facial dysmorphism including elongated faces, antimongolian eye slant, slight hypertelorism, and flat broad nasal root.
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Synophrys
  description: Confluent eyebrows occur in some patients.
  phenotype_term:
    preferred_term: Synophrys
    term:
      id: HP:0000664
      label: Synophrys
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: synophrys, hirsutism, low frontal hairline, bushy eyebrows, long eyelashes, deep-set eyes, large ears, and a bifid uvula
    explanation: The primary report documents this manifestation in a molecularly characterized patient or series.
- name: Precocious puberty
  description: Premature breast development at seven and menarche at nine occurred in one patient. Breast development at eight in another patient was explicitly early normal and is not counted as precocious puberty.
  phenotype_term:
    preferred_term: Precocious puberty
    term:
      id: HP:0000826
      label: Precocious puberty
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She had premature thelarche with breast development at the age of 7, but menstruation began at the age of 9.
    explanation: The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.
- name: Short stature
  description: Short stature was observed in several patients but growth is variable.
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: her height and weight were <1st and 11th percentile, respectively.
    explanation: The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.
- name: Supraventricular tachycardia
  description: Neonatal SVT was reported in one genetically characterized child. A causal association with SNAP29 deficiency remains unestablished.
  phenotype_term:
    preferred_term: Supraventricular tachycardia
    term:
      id: HP:0004755
      label: Supraventricular tachycardia
  evidence:
  - reference: PMID:40709160
    reference_title: 'Expanded Phenotypic Spectrum of Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome: A Rare Case Featuring Supraventricular Tachycardia and Tethered Spinal Cord.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: electrocardiography (ECG) revealed supraventricular tachycardia (SVT) with a heart rate of 280 beats per minute.
    explanation: The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.
- name: Tethered cord
  description: A tethered cord was reported in the same single child with neonatal SVT. This is a provisional spectrum observation, not an established common manifestation.
  phenotype_term:
    preferred_term: Tethered cord
    term:
      id: HP:0002144
      label: Tethered cord
  evidence:
  - reference: PMID:40709160
    reference_title: 'Expanded Phenotypic Spectrum of Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome: A Rare Case Featuring Supraventricular Tachycardia and Tethered Spinal Cord.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: a spinal magnetic resonance imaging (MRI) that revealed a tethered cord
    explanation: The report documents the observation; a single case does not establish population frequency or a specific causal mechanism.
genetic:
- name: SNAP29
  gene_term:
    preferred_term: SNAP29
    term:
      id: hgnc:11133
      label: SNAP29
  relationship_type: CAUSATIVE
  notes: >-
    Biallelic loss of SNAP29 function causes a variable neurocutaneous disorder. Homozygous and compound heterozygous sequence variants, and sequence-variant/deletion combinations, are documented. Contiguous-gene deletions can add phenotypes attributable to other genes. Missense candidates proposed in the 2013 22q11.2 series were supported chiefly by prediction and should not be equated with its two truncating-variant CEDNIK cases.
  variants:
  - name: c.223delG (p.Val75Serfs*28)
    description: Founding frameshift, historically reported as c.220delG using a different numbering convention. Patient fibroblasts showed markedly reduced RNA and protein.
  - name: c.487dup (p.Ser163Lysfs*6)
    description: Historically described as c.486insA or c.486_487insA. Transfection and organotypic assays support loss of function; truncated protein can be expressed and mislocalized.
  - name: c.2T>C start-loss
    description: Homozygous in two siblings with relatively greater motor/language acquisition and compound heterozygous with c.354dupG in a skin-negative hypomyelinating presentation. Residual translation is hypothesized, not established.
  - name: c.622G>T (p.Glu208*)
    description: Last-exon stop variant in one patient; escape from nonsense-mediated decay is predicted rather than experimentally demonstrated.
  - name: c.85C>T (p.Arg29*)
    description: Homozygous in a molecularly confirmed patient; both parents were heterozygous. Nonsense-mediated decay or truncation was predicted.
  - name: Pathogenic sequence allele in trans with a SNAP29-containing deletion
    description: Recessive unmasking can occur within 22q11.2 deletion syndrome or with a smaller deletion; additional deleted genes complicate phenotype attribution.
  evidence:
  - reference: PMID:15968592
    reference_title: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Using homozygosity mapping in two large families, we localized the disease gene to 22q11.2
    explanation: The founding families establish recessive inheritance.
  - reference: PMID:23231787
    reference_title: Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: as is the case with the SNAP29 abnormalities observed in patients 1 and 2 and their features of CEDNIK syndrome
    explanation: The primary deletion series supports recessive unmasking in its two truncating-variant cases.
  - reference: PMID:35093605
    reference_title: CEDNIK syndrome in a Brazilian patient with compound heterozygous pathogenic variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The patient presents a combination of a loss-of-function SNAP29 mutation and a ∼370 kb 22q11.2 deletion, each of these genetic variants inherited from one of the parents.
    explanation: A smaller deletion opposite a sequence allele is another documented configuration.
animal_models:
- name: C57BL/6 global and keratinocyte-specific Snap29 knockouts
  species: Mus musculus
  genotype: Global Snap29 knockout or Snap29 floxed / K14-Cre epidermal knockout
  publication: PMID:26747696
  description: Both lines develop severe congenital ichthyosis, acanthosis, hyperkeratosis, abnormal granules and neonatal lethality. Tissue-specific knockout demonstrates an epidermal requirement.
  modeled_mechanisms:
  - target: Lamellar Granule Maturation Failure
    description: Models abnormal granules and reduced cargo secretion.
    evidence:
    - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The amount of secreted LB contents between SG and SC was strongly reduced in mutant epidermis
      explanation: Electron microscopy directly demonstrates diminished secretion.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Normal-appearing granules coexist with malformed structures; severity exceeds human skin disease.
    fidelity: MODERATE
  - target: Epidermal Barrier Impairment
    description: Directly tests permeability and water loss.
    evidence:
    - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Both experiments indicate severe functional impairment of the epidermal barrier.
      explanation: Dye intrusion and dehydration directly test the barrier in mutant mice.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Neonatal barrier lethality and acanthosis are model-specific divergences from typical CEDNIK.
    fidelity: MODERATE
- name: Mixed CD1/FvB Snap29 exon-2 knockouts
  species: Mus musculus
  genotype: Two exon-2 deletion lines maintained on a mixed CD1/FvB background
  publication: PMID:31633066
  description: Most mutants survive to adulthood. They show variable skin disease, gait and grip abnormalities and retinal defects. Male infertility is a mouse finding and is not established as a human CEDNIK feature.
  modeled_mechanisms:
  - target: Epidermal Barrier Impairment
    description: Tests delayed prenatal barrier acquisition followed by normalization.
    evidence:
    - reference: PMID:31633066
      reference_title: Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: although skin barrier formation is delayed in homozygous mutant embryos, a proper skin barrier was present at birth.
      explanation: The mixed-background model limits generalization of the neonatal barrier defect.
    relationship: FAILS_TO_RECAPITULATE
    model_scale: TISSUE
    limitations: A functional barrier exists at birth despite later skin changes, unlike the C57BL/6 model.
    fidelity: MODERATE
  - target: Abnormal Neural Development
    description: Tests whether mutant mice reproduce human brain malformations.
    evidence:
    - reference: PMID:31633066
      reference_title: Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: we did not detect any morphological changes during neurogenesis or in adult brains
      explanation: The primary study explicitly reports the negative structural result.
    relationship: FAILS_TO_RECAPITULATE
    model_scale: TISSUE
    limitations: Motor and retinal abnormalities occur without detectable cortical malformations; sporadic seizures were observed but not systematically quantified.
    fidelity: MODERATE
- name: snap29 K164* and N171fs zebrafish
  species: Danio rerio
  genotype: ENU K164* and CRISPR frameshift alleles; detailed phenotyping chiefly K164*
  publication: PMID:30718891
  description: Mutants develop microcephaly, early apoptotic-cell excess, neuromuscular disorganization, feeding failure and early death. K164* RNA is markedly reduced; the frameshift allele retains RNA. Transient GFP-snap29 expression improves selected phenotypes and prolongs survival without a durable adult rescue.
  modeled_mechanisms:
  - target: Altered Motor Neuron Organization
    description: Models missing trigeminal motor nuclei and axonal hyperbranching.
    evidence:
    - reference: PMID:30718891
      reference_title: A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: These results suggest that Snap29 is required to ensure correct neuromuscular system development in zebrafish.
      explanation: The mutant motor-neuron imaging establishes a vertebrate developmental phenotype.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Larval zebrafish anatomy, feeding mechanics and developmental timing differ from humans.
    fidelity: MODERATE
  - target: Context-Dependent Autophagic Clearance Disturbance
    description: Measures LC3/p62 accumulation and abnormal organelles.
    evidence:
    - reference: PMID:30718891
      reference_title: A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We observed a mild increase in both LC3II and the autophagy adapter p62
      explanation: Whole-larva markers support altered clearance, without a direct fusion-flux measurement.
    relationship: MEASURES
    model_scale: CELLULAR
    limitations: Static markers and ultrastructure support disturbed clearance but do not directly measure fusion flux.
    fidelity: MODERATE
  - target: Abnormal Keratinocyte Differentiation
    description: Compares mutant epidermal organization with mammalian skin.
    evidence:
    - reference: PMID:30718891
      reference_title: A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: mutants show a thinner peridermal layer composed of more elongated cells
      explanation: The thinner mutant periderm contrasts with human epidermal hyperkeratosis.
    relationship: FAILS_TO_RECAPITULATE
    model_scale: TISSUE
    limitations: Thinner periderm and lower keratin differ from human hyperkeratosis; larval fish skin has different layers.
    fidelity: LOW
experimental_models:
- name: SNAP29-knockdown three-dimensional human keratinocyte organotypic culture
  experimental_model_type: OTHER
  publication: PMID:21073448
  description: Primary human keratinocyte organotypic cultures reproduce epidermal histological abnormalities after SNAP29 downregulation.
  modeled_mechanisms:
  - target: Abnormal Keratinocyte Differentiation
    description: Models differentiation changes in human epidermal culture.
    evidence:
    - reference: PMID:21073448
      reference_title: CEDNIK syndrome results from loss-of-function mutations in SNAP29.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: we could replicate histological features typical for CEDNIK syndrome in three-dimensional primary human keratinocyte organotypic cell cultures downregulated for SNAP29.
      explanation: Human organotypic cultures reproduce histological features after SNAP29 knockdown.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Engineered knockdown rather than patient isogenic correction; full assessment is limited to the available abstract and later descriptions of the study.
    fidelity: MODERATE
- name: CEDNIK patient-derived transformed fibroblasts
  experimental_model_type: CELL_LINE
  publication: PMID:20305790
  description: Two transformed patient lines show delayed transferrin and integrin recycling, altered focal adhesions and reduced motility. Uptake and selected secretory/retrograde cargo assays were preserved.
  modeled_mechanisms:
  - target: Impaired Endocytic Recycling
    description: Measures patient-cell recycling kinetics.
    evidence:
    - reference: PMID:20305790
      reference_title: Loss of SNAP29 impairs endocytic recycling and cell motility.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: During the chase times, disappearance of transferrin from CEDNIK cells was attenuated by 26–30% compared to control cells
      explanation: The patient-fibroblast study distinguishes recycling defects from preserved uptake and selected other trafficking routes.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Nonisogenic transformed fibroblasts do not demonstrate neuronal migration.
    fidelity: MODERATE
  - target: Reduced Fibroblast Motility
    description: Measures spreading and wound closure.
    evidence:
    - reference: PMID:20305790
      reference_title: Loss of SNAP29 impairs endocytic recycling and cell motility.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Impaired beta1-integrin recycling affected cell motility, as reflected by changes in cell spreading and wound healing.
      explanation: The primary fibroblast assay documents impaired motility.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: A fibroblast migration readout is not a direct assay of cortical development.
    fidelity: MODERATE
- name: SNAP29-depleted human neuroepithelial stem cells
  experimental_model_type: IPSC_DERIVED_MODEL
  publication: PMID:33718375
  description: Engineered knockdown in human iPSC-derived neuroepithelial stem cells produces Golgi fragmentation, spindle abnormalities and micronuclei.
  modeled_mechanisms:
  - target: Golgi Organization Defects
    description: Measures Golgi organization in a neural-lineage model.
    evidence:
    - reference: PMID:33718375
      reference_title: Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Depleted NES cells display GA fragmentation.
      explanation: The figure directly documents the neural-lineage structural phenotype.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Cells were not derived from a CEDNIK patient; knockdown is not a biallelic patient variant.
    fidelity: MODERATE
  - target: Defective Mitotic Chromosome Segregation
    description: Measures micronuclear formation and spindle changes.
    evidence:
    - reference: PMID:33718375
      reference_title: Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: SNAP29 KD NES cells often formed micronuclei, compared to mock-treated controls
      explanation: The human neuroepithelial model supplies a neural-lineage readout.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Does not reproduce a complete developing cortex or establish the cause of polymicrogyria.
    fidelity: MODERATE
- name: SNAP29 knockdown and rescue in HeLa and U2OS cells
  experimental_model_type: CELL_LINE
  publication: PMID:27647876
  description: Knockdown destabilizes kinetochore assembly and chromosome segregation; siRNA-resistant SNAP29 rescues selected mitotic readouts. The Q1Q2 trapping construct is an experimental mutant, not a human CEDNIK allele.
  modeled_mechanisms:
  - target: Defective Mitotic Chromosome Segregation
    description: Tests kinetochore localization and mitotic phenotypes.
    evidence:
    - reference: PMID:27647876
      reference_title: An essential step of kinetochore formation controlled by the SNARE protein Snap29.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: KNL1 and ZWINT are not found at KTs in SNAP29 KD cells
      explanation: Loss of kinetochore localization occurs without a corresponding reduction in total protein.
    relationship: PERTURBS
    model_scale: CELLULAR
    limitations: Transformed non-neural cells and overexpression rescue limit disease-specific inference.
    fidelity: MODERATE
- name: Snap29-null primary mouse fibroblasts
  experimental_model_type: PRIMARY_CELL_CULTURE
  publication: PMID:26747696
  description: Basal and starvation immunoblots show increased LC3B-II, largely unchanged p62 and approximately fivefold CHOP induction.
  modeled_mechanisms:
  - target: Endoplasmic Reticulum Stress
    description: Measures the CHOP stress response.
    evidence:
    - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: western blot analysis revealed a strong 5-fold induction of CHOP in mutant fibroblasts
      explanation: The readout is from cultured mouse fibroblasts, not a direct patient-tissue or epidermal measurement.
    relationship: MEASURES
    model_scale: CELLULAR
    limitations: Cultured mouse cells; static immunoblots do not establish a causal route to patient brain disease.
    fidelity: MODERATE
  - target: Context-Dependent Autophagic Clearance Disturbance
    description: Measures static autophagy-marker changes.
    evidence:
    - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: p62/SQSTM1 protein amounts remained largely unchanged
      explanation: Unchanged p62 prevents interpretation of LC3-II accumulation as proof of blocked fusion.
    relationship: MEASURES
    model_scale: CELLULAR
    limitations: No lysosomal-inhibitor turnover assay; the authors favor induction, potentially driven by ER stress.
    fidelity: MODERATE
- name: Snap29-null mouse embryonic stem cells
  experimental_model_type: CELL_LINE
  publication: PMID:36614195
  description: Two CRISPR clones and knockdown lines retain core pluripotency markers; differentiation is altered. Undifferentiated Snap29-null cells do not accumulate LC3-II/p62 unless Snap47 is also depleted.
  modeled_mechanisms:
  - target: Context-Dependent Autophagic Clearance Disturbance
    description: Tests dependence of autophagy markers on cell state and SNAP47.
    evidence:
    - reference: PMID:36614195
      reference_title: Snap29 Is Dispensable for Self-Renewal Maintenance but Required for Proper Differentiation of Mouse Embryonic Stem Cells.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Snap29 knockout or knockdown in mouse ESCs did not lead to the accumulation of the autophagosome marker LC3-II or the universal autophagic substrate SQSTM1/p62
      explanation: The negative finding limits a universal autophagy-block model.
    relationship: FAILS_TO_RECAPITULATE
    model_scale: CELLULAR
    limitations: The negative result applies to undifferentiated mouse ESCs with intact Snap47. Differentiation day seven and fourteen have different marker patterns; static levels do not measure flux directly.
    fidelity: LOW
- name: CRISPR SNAP29-null MRC5Vi fibroblast clone
  experimental_model_type: CELL_LINE
  publication: PMID:34069872
  description: An engineered immortalized human fetal-lung fibroblast clone lacks detectable SNAP29 and has reduced growth. The study creates a model; it does not measure autophagic flux or validate a CEDNIK treatment.
  modeled_mechanisms:
  - target: SNAP29 Loss of Function
    description: Removes detectable SNAP29 in a human cell line.
    evidence:
    - reference: PMID:34069872
      reference_title: Generation and Characterization of a CRISPR/Cas9-Mediated SNAP29 Knockout in Human Fibroblasts.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: By Western blot analyses no SNAP29 protein was detected in MRC5Vi SNAP29 KO cells
      explanation: The knockout model lacks detectable target protein.
    relationship: PERTURBS
    model_scale: CELLULAR
    limitations: One clone with persistent lentiviral Cas9; off-target or insertion effects and lack of isogenic rescue limit phenotype attribution.
    fidelity: LOW
discussions:
- discussion_id: cednik_brain_mechanism
  kind: KNOWLEDGE_GAP
  prompt: >-
    What does loss of SNAP29-dependent vesicle fusion do in the developing brain to
    produce corpus callosum dysgenesis and polymicrogyria?
  attaches_to:
  - pathophysiology#Abnormal Neural Development
  - pathophysiology#Defective Mitotic Chromosome Segregation
  rationale: >-
    Human neuroepithelial stem-cell knockdown establishes Golgi, spindle and nuclear abnormalities; patient fibroblasts show defective recycling and motility. The unresolved question is which of these routes causes specific human malformations or myelin loss. Patient-derived neural models with isogenic correction and developmental readouts could distinguish these contributions.
- discussion_id: cednik_expressivity
  kind: KNOWLEDGE_GAP
  prompt: >-
    Which allele-dependent and background-dependent factors explain variable skin, myelin and developmental manifestations?
  attaches_to:
  - genetic#SNAP29
  rationale: >-
    The start-loss siblings have relatively preserved skills, yet one later regressed; skin-negative compound heterozygotes and variable keratoderma are documented. Protein mislocalization, residual translation and genetic background are distinguishable hypotheses. The mouse background effect demonstrates a model modifier effect, not a proven human modifier.
- discussion_id: cednik_autophagy_contribution
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    When does SNAP29 loss impair autophagic clearance, and how much does this contribute to human skin and neurological disease?
  attaches_to:
  - pathophysiology#Context-Dependent Autophagic Clearance Disturbance
  - pathophysiology#Endoplasmic Reticulum Stress
  rationale: >-
    The 2016 static LC3-II/p62/CHOP measurements were made in primary mouse fibroblasts and cannot distinguish induction from reduced clearance. Zebrafish and mouse ESCs show different marker responses, with a SNAP47-dependent effect in ESCs. Flux assays with appropriate turnover controls in patient keratinocytes and neural cells, alongside isogenic rescue, would test the contribution to human disease.
- discussion_id: cednik_model_brain_skin_divergence
  kind: HUMAN_MODEL_MISMATCH
  prompt: Which model backgrounds reproduce the human cortical and epidermal phenotypes?
  attaches_to:
  - animal_models#Mixed CD1/FvB Snap29 exon-2 knockouts
  - animal_models#snap29 K164* and N171fs zebrafish
  rationale: Mixed-background mice survive with a functional neonatal barrier and no detectable cortical malformations. Zebrafish have a thinner periderm rather than hyperkeratosis. These divergences matter when selecting readouts for rescue experiments; neurological or skin improvement in one model does not demonstrate correction of the corresponding human mechanism.
notes: >-
  The clinical spectrum is broader than the CEDNIK acronym: skin disease, neuropathy and cortical malformations are individually variable, and some individuals survive into adulthood. Cell-model pathways explain candidate disease mechanisms without establishing that every trafficking readout causes every human phenotype. The Max Planck PDF is the accepted journal proof of Schiller et al., Establishment of Two Mouse Models for CEDNIK Syndrome (PMID:26747696).
diagnosis:
- name: Molecular diagnosis
  description: Sequence analysis of SNAP29, usually through exome or an appropriate panel, should be interpreted together with deletion/duplication assessment and parental segregation. Apparent homozygosity can reflect a variant opposite a deletion. Clinical suspicion is appropriate despite absent ichthyosis, keratoderma or polymicrogyria; uncertain missense predictions alone are insufficient to establish CEDNIK.
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Clinical exome or targeted sequencing were performed to elucidate the molecular genetic cause
    explanation: The cohort was molecularly characterized.
  - reference: PMID:35093605
    reference_title: CEDNIK syndrome in a Brazilian patient with compound heterozygous pathogenic variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: each of these genetic variants inherited from one of the parents
    explanation: Segregation demonstrated the sequence-variant/deletion configuration.
- name: Brain MRI and longitudinal neurological assessment
  description: MRI characterizes cortical, callosal and white-matter abnormalities. Serial imaging may distinguish impaired myelination from later loss when the clinical course changes; the existing series does not establish a universal scanning interval.
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Serial imaging in future patients could help determine which SNAP29 variants are associated with this pattern of white matter disease.
    explanation: The authors propose longitudinal imaging to clarify variable white-matter disease.
- name: Peripheral neurophysiology
  description: Nerve-conduction studies and electromyography can characterize suspected neuropathy and distinguish demyelinating or neurogenic findings.
  evidence:
  - reference: PMID:35359556
    reference_title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the electroneurographic study was confirmatory for the presence of diffuse sensorimotor demyelinating polyneuropathy.
    explanation: Electrophysiology established the neuropathy subtype in this patient.
- name: Swallowing, hearing and visual assessment
  description: Clinical assessment is directed by feeding, hearing and visual difficulties. Swallow studies can detect aspiration; ophthalmologic and auditory evaluation distinguish optic-nerve, cortical, ocular and sensorineural abnormalities.
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: A swallow study showed dysphagia and aspiration of thin liquids
    explanation: The primary case demonstrates an actionable swallowing finding.
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Ophthalmologic examination showed nystagmus and foveal hypoplasia.
    explanation: Ophthalmology resolves specific visual findings.
treatments:
- name: Emollient skin care
  description: Regular emollients were used for xerosis in a molecularly confirmed patient. Published CEDNIK-specific treatment evidence is descriptive.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Topical emollient therapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:38590735
    reference_title: Keratoderma and ichthyosis as valuable features for the diagnosis of CEDNIK syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The patient has diffuse xerosis and subtle erythema on extremities since birth, both managed with emollients.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Ichthyosis
    term:
      id: HP:0008064
      label: Ichthyosis
- name: Swallowing-directed feeding modification
  description: Documented aspiration can prompt texture modification. In one confirmed patient, thin-liquid aspiration on swallow study led to thickened liquids.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Swallowing-directed texture modification
    term:
      id: NCIT:C15447
      label: Dietary Intervention
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: he was fed only thickened liquids until 7 years.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  target_mechanisms:
  - target: Impaired Swallowing
    treatment_effect: BYPASSES
    description: Texture modification adapts feeding to the demonstrated swallowing problem; it does not restore SNAP29.
    evidence:
    - reference: PMID:29051910
      reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: he was fed only thickened liquids until 7 years.
      explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
- name: Gastrostomy feeding
  description: Gastrostomy can provide nutrition when feeding difficulties and poor growth warrant it; it does not by itself eliminate aspiration risk.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Gastrostomy tube placement
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At birth, patient 3 had difficulty feeding and received a G-tube at the age of 2 for failure to thrive.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  - preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
- name: Individualized antiseizure medication
  description: Treatment is selected for the individual seizure disorder. Phenobarbitone-associated seizure resolution is described in one child; no comparative CEDNIK regimen is established.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Anticonvulsant Therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
    therapeutic_agent:
    - preferred_term: phenobarbital
      term:
        id: CHEBI:8069
        label: phenobarbital
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: He developed seizures at 4 months with multifocal epileptiform discharges on EEG, for which he took phenobarbitone until seizures resolved at the age of 2.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
- name: Physical and occupational rehabilitation
  description: Therapy and mobility aids address functional limitations. One molecularly confirmed child used a wheelchair, walker, gait trainer and ankle-foot orthoses alongside therapy.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The patient is currently enrolled in third grade and receives physical and occupational and swimming therapy.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
- name: Augmentative communication
  description: Picture-board communication and individualized learning supports may assist individuals with limited speech.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Augmentative communication support
    term:
      id: NCIT:C15315
      label: Rehabilitation
  evidence:
  - reference: PMID:29051910
    reference_title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: including communication by picture board and understanding of simple learning games.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
- name: Corrective strabismus surgery
  description: Ophthalmologic management includes corrective surgery when indicated; it does not correct optic-nerve or cerebral visual pathology.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Strabismus correction
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She is hyperopic and required 3 corrective surgeries for strabismus.
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
- name: Symptomatic gastrointestinal treatment
  description: Reflux and constipation are treated according to the individual problem. Omeprazole and laxatives are reported in affected children; these observations do not establish a syndrome-specific regimen.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Symptomatic gastrointestinal pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: omeprazole
      term:
        id: CHEBI:7772
        label: omeprazole
  evidence:
  - reference: PMID:33977139
    reference_title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She takes omeprazole for gastroesophageal reflux
    explanation: The primary case records supportive care; it does not establish controlled treatment efficacy.
  target_phenotypes:
  - preferred_term: Gastroesophageal reflux
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
  - preferred_term: Constipation
    term:
      id: HP:0002019
      label: Constipation
- name: Genetic counseling
  description: Counseling uses the confirmed variants and parental testing to explain recessive inheritance and family testing. A deletion on one allele requires attention to its extent and additional gene content.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:35093605
    reference_title: CEDNIK syndrome in a Brazilian patient with compound heterozygous pathogenic variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: each of these genetic variants inherited from one of the parents
    explanation: The documented segregation supports family-specific counseling.
differential_diagnoses:
- name: Sjogren-Larsson syndrome
  disease_term:
    preferred_term: Sjogren-Larsson syndrome
    term:
      id: MONDO:0010031
      label: Sjogren-Larsson syndrome
  description: Another neuroichthyotic disorder considered in the founding diagnostic workup.
  distinguishing_features:
  - The founding series excluded overlapping metabolic disorders through biochemical evaluation; SNAP29 molecular findings establish CEDNIK.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
    reference_title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: a large number of syndromes with closely related clinical manifestations, including Sjogren Larsson syndrome
    explanation: The primary diagnostic workup explicitly considered this overlap.
- name: MEDNIK syndrome
  disease_term:
    preferred_term: MEDNIK syndrome
    term:
      id: MONDO:0012251
      label: MEDNIK syndrome
  description: A related disorder of intracellular trafficking with neurological and cutaneous overlap.
  distinguishing_features:
  - MEDNIK is associated with AP1S1 rather than SNAP29; molecular testing resolves the etiologic distinction.
  evidence:
  - reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    reference_title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    directness: DIRECT
    snippet: mutations in AP1S1 encoding a component of adaptor protein complex 1
    explanation: The mouse paper summarizes the established human trafficking-disorder differential.
references:
- reference: PMID:15968592
  title: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.
- reference: PMID:31748968
  title: Compound heterozygous mutations in SNAP29 is associated with Pelizaeus-Merzbacher-like disorder (PMLD).
- reference: PMID:33977139
  title: New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.
- reference: PMID:38590735
  title: Keratoderma and ichthyosis as valuable features for the diagnosis of CEDNIK syndrome.
- reference: PMID:21073448
  title: CEDNIK syndrome results from loss-of-function mutations in SNAP29.
- reference: url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader
  title: A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC
- reference: url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
  title: https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content
- reference: PMID:31633066
  title: Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.
- reference: PMID:20305790
  title: Loss of SNAP29 impairs endocytic recycling and cell motility.
- reference: PMID:33718375
  title: Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.
- reference: PMID:27647876
  title: An essential step of kinetochore formation controlled by the SNARE protein Snap29.
- reference: PMID:30718891
  title: A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.
- reference: PMID:36614195
  title: Snap29 Is Dispensable for Self-Renewal Maintenance but Required for Proper Differentiation of Mouse Embryonic Stem Cells.
- reference: PMID:35359556
  title: CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.
- reference: PMID:29051910
  title: 'CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.'
- reference: PMID:35229899
  title: CEDNIK syndrome with phenotypic variability.
- reference: PMID:40709160
  title: 'Expanded Phenotypic Spectrum of Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome: A Rare Case Featuring Supraventricular Tachycardia and Tethered Spinal Cord.'
- reference: PMID:23231787
  title: Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.
- reference: PMID:35093605
  title: CEDNIK syndrome in a Brazilian patient with compound heterozygous pathogenic variants.
- reference: PMID:34069872
  title: Generation and Characterization of a CRISPR/Cas9-Mediated SNAP29 Knockout in Human Fibroblasts.

📚

References & Deep Research

References

PMID:15968592

A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.

No top-level findings curated for this source.

PMID:31748968

Compound heterozygous mutations in SNAP29 is associated with Pelizaeus-Merzbacher-like disorder (PMLD).

No top-level findings curated for this source.

PMID:33977139

New Cohort of Patients With CEDNIK Syndrome Expands the Phenotypic and Genotypic Spectra.

No top-level findings curated for this source.

PMID:38590735

Keratoderma and ichthyosis as valuable features for the diagnosis of CEDNIK syndrome.

No top-level findings curated for this source.

PMID:21073448

CEDNIK syndrome results from loss-of-function mutations in SNAP29.

No top-level findings curated for this source.

url:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224527/?report=reader

A Mutation in SNAP29, Coding for a SNARE Protein Involved in Intracellular Trafficking, Causes a Novel Neurocutaneous Syndrome Characterized by Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Palmoplantar Keratoderma - PMC

No top-level findings curated for this source.

url:https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content

https://pure.mpg.de/rest/items/item_2248126/component/file_2248124/content

No top-level findings curated for this source.

PMID:31633066

Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome.

No top-level findings curated for this source.

PMID:20305790

Loss of SNAP29 impairs endocytic recycling and cell motility.

No top-level findings curated for this source.

PMID:33718375

Activity of the SNARE Protein SNAP29 at the Endoplasmic Reticulum and Golgi Apparatus.

No top-level findings curated for this source.

PMID:27647876

An essential step of kinetochore formation controlled by the SNARE protein Snap29.

No top-level findings curated for this source.

PMID:30718891

A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development.

No top-level findings curated for this source.

PMID:36614195

Snap29 Is Dispensable for Self-Renewal Maintenance but Required for Proper Differentiation of Mouse Embryonic Stem Cells.

No top-level findings curated for this source.

PMID:35359556

CErebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome with Brain Stem Malformation.

No top-level findings curated for this source.

PMID:29051910

CEDNIK: Phenotypic and Molecular Characterization of an Additional Patient and Review of the Literature.

No top-level findings curated for this source.

PMID:35229899

CEDNIK syndrome with phenotypic variability.

No top-level findings curated for this source.

PMID:40709160

Expanded Phenotypic Spectrum of Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma (CEDNIK) Syndrome: A Rare Case Featuring Supraventricular Tachycardia and Tethered Spinal Cord.

No top-level findings curated for this source.

PMID:23231787

Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.

No top-level findings curated for this source.

PMID:35093605

CEDNIK syndrome in a Brazilian patient with compound heterozygous pathogenic variants.

No top-level findings curated for this source.

PMID:34069872

Generation and Characterization of a CRISPR/Cas9-Mediated SNAP29 Knockout in Human Fibroblasts.

No top-level findings curated for this source.

Deep Research

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: CEDNIK Syndrome (SNAP29) · 2026-09-17T14:47:34Z · View source

De-novo curation of CEDNIK syndrome (MONDO:0012290), biallelic SNAP29 loss of function, from a Perplexity sonar-deep-research run (research/CEDNIK_Syndrome-deep-research-perplexity.md, 373s, 18 citations). The report was a lead only. It contains exactly one PMID string in its whole body (PMID:15968592), and its citations sidecar lists web URLs rather than identifiers, so all four references here were found independently through PubMed esearch and cached with just fetch-reference. Its ontology suggestions were not used: the run's own Term Validation section records mislabelled bindings including GO:0031017 offered as 'lamellar body' (GO: exocrine pancreas development), GO:0048812 offered as 'epidermal cell differentiation' (GO: neuron projection morphogenesis) and HP:0000579 offered as 'optic nerve hypoplasia' (HP: Nasolacrimal duct obstruction). Every CURIE in this entry was looked up against OLS in the step it was written; hgnc:11133 was read from the repository's own cache/hgnc/terms.csv. References: PMID:15968592 (Sprecher, founding description and the lamellar granule lesion in patient skin), PMID:21073448 (second homozygous allele, transfection proof of loss of function, human organotypic replication), PMID:26747696 (two knockout mouse models, lamellar body and autophagy readouts), PMID:31633066 (neurological/ophthalmological mouse model, and the 22q11.2 locus relationship). Curation judgements worth recording. The entry deliberately types its two arms differently: the epidermal chain is DIRECT because it is measured in patient skin and reproduced in both a keratinocyte-specific mouse and human organotypic culture, while every edge out of the Neuroectodermal Developmental Disruption node is INDIRECT_UNKNOWN_INTERMEDIATES because the shared neuroectodermal origin is an argument for expecting a connection, not a mechanism. Six clinical features are cited from the introduction of a mouse paper where that introduction states the human clinical picture; they carry evidence_source HUMAN_CLINICAL with quote_role BACKGROUND, because grading them MODEL_ORGANISM would assert that a mouse measured human deafness. The autophagy arm is recorded as a HUMAN_MODEL_MISMATCH rather than a plain knowledge gap: the LC3B-II, p62 and CHOP readouts exist but only in mouse epidermis. Peripheral neuropathy and hearing impairment are bound to the nearest available HPO terms with the uncommitted clinical description kept in preferred_term, because no located source characterises either as demyelinating/axonal or sensorineural/conductive in genetically confirmed patients. Validation: just validate passed; 30/30 snippets verified against cached references; just validate-terms passed; check-entity-refs, check-causal-targets, check-duplicate-keys and check-qualifier-terms all OK; 10 of 11 phenotypes causally connected (90.9%). just check-genereviews reports NO_CHAPTER, recorded in the entry's notes.

Perplexity ▸

1. Disease Information

sonar-deep-research 18 citations 2026-09-17T14:25:03.750604

1. Disease Information

1.1 Definition and Concise Overview

CEDNIK syndrome is defined as a neurocutaneous Mendelian disorder characterized by a distinctive constellation of cerebral malformations, peripheral neuropathy, ichthyosis, and palmoplantar keratoderma attributable to biallelic pathogenic variants in SNAP29.[3][6][11] OMIM (entry 609528) describes it as “cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome,” emphasizing global developmental delay, hypotonia, roving eye movements or nystagmus, poor motor skills, and impaired intellectual development with speech delay, together with variable microcephaly, feeding difficulties, seizures, ocular anomalies, hearing loss, and dysmorphic facial features.[3][14] Orphanet similarly categorizes CEDNIK as a neurocutaneous syndrome with severe developmental abnormalities of the central nervous system and abnormal epidermal differentiation, explicitly tying its defining clinical signs to the acronym CEDNIK.[6] GARD (Genetic and Rare Diseases Information Center) and Malacards reinforce this characterization, noting that CEDNIK is a rare genetic neurocutaneous disease presenting with global developmental delay, hypotonia, intellectual disability, ichthyosis, and palmoplantar keratoderma, often accompanied by microcephaly and other systemic features.[1][14]

From a mechanistic standpoint, the disease results from loss of SNAP29, a synaptosomal‑associated protein that belongs to the SNARE family and mediates membrane fusion events in exocytosis, endocytosis, autophagy, and ciliogenesis.[9][12][16] Sprecher et al. localized the disease gene to 22q11.2 and identified a homozygous one‑base‑pair deletion in SNAP29 in all affected individuals, leading to complete absence of the protein.[11][12] Subsequent case reports and cohort analyses have confirmed that essentially all patients with the CEDNIK phenotype harbor biallelic truncating or severe loss‑of‑function variants in SNAP29.[4][5][9][10][15] Clinically, CEDNIK is a progressive neurodegenerative disorder: developmental abnormalities are apparent from early infancy, and neurologic dysfunction and cutaneous changes worsen over time, culminating in profound disability and, in most reported cases, death in childhood or adolescence.[4][13][14][15]

1.2 Key Disease Identifiers and Ontology Mapping

CEDNIK syndrome is indexed across multiple disease ontologies and rare disease registries, which is essential for standardized annotation and knowledge integration. OMIM assigns the phenotype entry 609528 to “cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome,” with SNAP29 (MIM 604202) as the causal gene.[3][14] Orphanet lists CEDNIK under ID 66631, categorizing it as a neurocutaneous syndrome with autosomal recessive inheritance.[6][17] In the MONDO ontology, CEDNIK syndrome corresponds to MONDO:0012290, as referenced by ClinVar for SNAP29 variants associated with this disease.[17] MedGen and related NCBI resources also index CEDNIK, often using the synonym “CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME.”[17]

Formal ICD‑10 or ICD‑11 codes specifically dedicated to CEDNIK have not been widely documented, and in clinical practice patients are generally coded under broader categories such as “other specified congenital malformations of brain” or “other specified ichthyosis,” reflecting the rarity and lack of a specific ICD label.[3][6] In MeSH and SNOMED CT, CEDNIK is typically represented indirectly through component phenotypes (e.g., “ichthyosis,” “peripheral neuropathy,” “brain malformations”) rather than a standalone disease concept, although emerging rare disease terminologies may offer dedicated terms.[13][14] In the Human Phenotype Ontology (HPO), CEDNIK is associated with a rich set of terms including HP:0001263 (global developmental delay), HP:0001252 (hypotonia), HP:0001250 (seizures), HP:0007568 (palmoplantar keratoderma), and HP:0008064 (ichthyosis), among others, providing granular phenotype descriptors.[13][14][15]

1.3 Synonyms and Alternative Names

Multiple synonyms and alternative names for CEDNIK syndrome are used in the literature, reflecting both the acronym and descriptive phrasing. OMIM and PubMed commonly use “cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome” or simply “CEDNIK syndrome.”[3][11] Malacards lists “Cednik Syndrome” and “Cerebral Dysgenesis‑Neuropathy‑Ichthyosis‑Keratoderma (CEDNIK) syndrome,” emphasizing the neuro‑ichthyotic nature of the condition.[14] Orphanet uses the French designation “syndrome CEDNIK” but defines it similarly as a neurocutaneous syndrome characterized by severe developmental abnormalities and abnormal epidermal differentiation.[6] ClinVar and MONDO consolidate these synonyms under the standardized label CEDNIK syndrome, tied to SNAP29‑related cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma.[17]

These synonyms are important for mapping across databases and literature sources. For ontology purposes, MONDO:0012290 captures all synonyms, while specific phenotypic domains map to distinct HPO terms, and causal genetics map to HGNC:11186 (SNAP29) and relevant GO process and component terms described later.[16] The acronym CEDNIK itself encodes the four core features that remain central to both clinical recognition and research framing of the disease: CErebral dysgenesis, Neuropathy, Ichthyosis, and palmoplantar Keratoderma.[1][6][13]

1.4 Nature of the Information: Case‑Based versus Aggregated Resources

Because CEDNIK syndrome is extremely rare, most information derives from detailed case reports, small family series, and a limited number of cohort analyses, rather than large epidemiologic or clinical trial datasets. The original description by Sprecher et al. (Am J Hum Genet 2005, PMID 15968592, https://pubmed.ncbi.nlm.nih.gov/15968592) was based on two large consanguineous Arab families with multiple affected children, combining clinical, neuroimaging, dermatopathology, and genetic data.[11] Subsequent reports have described individual patients from Pakistan, Iran, India, and other regions, each adding nuance to the phenotypic and genotypic spectrum.[5][10] A landmark Neurology Genetics paper (Mah‑Som et al., 2021, https://www.neurology.org/doi/10.1212/NXG.0000000000000553) compiled 19 individuals from 10 unrelated families, providing the first systematic expansion of the CEDNIK cohort and highlighting variability in dermatologic and peripheral neuropathy manifestations.[9][14]

Dermatologic case series have further refined the cutaneous phenotype. For example, a recent study in the Journal of the American Academy of Dermatology (PMCID: PMC10999791) analyzed 20 patients ultimately diagnosed with CEDNIK syndrome, emphasizing that 100% showed ichthyosis and 85% exhibited keratoderma, and arguing that “keratoderma and ichthyosis [are] valuable features for the diagnosis of CEDNIK syndrome.”[15] In addition, mechanistic cell biology studies using fibroblasts derived from CEDNIK patients have been crucial in elucidating how SNAP29 deficiency impairs endocytic recycling and cell motility.[12] Curated disease‑level resources such as OMIM, Orphanet, GARD, Malacards, JensenLab’s DISEASES database, and ClinVar integrate these individual patient‑level findings into aggregate entries that summarize key clinical features, genetics, and mechanisms.[1][3][6][14][16][17]

In this report, evidence is distinguished by source type. Human clinical evidence stems from case reports, family series, and small cohorts (e.g., Sprecher et al. 2005; Mah‑Som et al. 2021; Fuchs‑Telem et al. cited in Malacards; dermatologic series in 2023–2024).[11][4][9][14][15] In vitro mechanistic evidence comes from fibroblast studies and neuronal models of SNAP29 perturbation.[12] Computational and curated evidence is drawn from database entries that synthesize genetic and functional information.[3][14][16][17] This combination is typical for ultra‑rare Mendelian disorders and must be considered when assessing the strength and generalizability of conclusions.

2. Etiology and Risk Factors

2.1 Primary Causal Factors: Genetic Basis in SNAP29

The primary and, to date, only established causal factor for CEDNIK syndrome is biallelic pathogenic variants in the synaptosomal‑associated protein 29 (SNAP29) gene.[3][4][11] OMIM clearly states that “CEDNIK syndrome is caused by homozygous or compound heterozygous mutation in the SNAP29 gene on chromosome 22q11,” and uses a number sign (#) with the phenotype entry to indicate that the disorder’s material basis is in SNAP29.[3] Sprecher et al. localized the disease gene to a 4 Mb region on 22q11.2 by linkage analysis, with a maximum multipoint LOD score of 4.85 at marker D22S446, and subsequently identified a homozygous 1‑bp deletion (c.220delG) in all affected family members.[11][3] This deletion results in a frameshift and premature termination of translation, leading to complete absence of the SNAP29 protein.[11][12]

Later studies have confirmed that CEDNIK arises from loss‑of‑function variants in SNAP29, including other frameshift mutations such as c.486_487insA (p.Ser163LysfsTer6) in South‑Indian and Pakistani patients, and c.487dupA (p.A162fs) in an Iranian patient, all of which cause truncation and functional null alleles.[5][10] A recent phenotypic spectrum study reiterated that “pathogenic variants in the SNAP29 gene cause CEDNIK syndrome (MIM 609528), with an autosomal recessive pattern of inheritance.”[4] In every patient where genetic testing has been performed and the classical CEDNIK phenotype is present, biallelic SNAP29 variants have been identified, strongly supporting a monogenic, fully penetrant causal relationship.[3][4][9][11][15]

Mechanistically, SNAP29 belongs to the SNARE family of membrane fusion proteins and is required for vesicle trafficking in multiple pathways, including endocytosis, autophagy, and lamellar granule maturation in the epidermis.[9][12][16] Loss‑of‑function variants abrogate SNAP29 expression, resulting in defective vesicle fusion with downstream consequences for neuroectodermal tissues.[11][12][15] No alternative genetic causes have been documented for clinically typical CEDNIK syndrome, although the broader category of “neuro‑ichthyotic” disorders includes other genes related to lipid metabolism, glycoprotein synthesis, and vesicle trafficking.[13] Thus, CEDNIK syndrome is best conceptualized as a single‑gene, autosomal recessive, loss‑of‑function disorder of SNAP29.

2.2 Genetic Risk Factors: Causal Variants, Susceptibility, and Modifiers

Within the genetic etiology of CEDNIK, the principal risk factor is being homozygous or compound heterozygous for a pathogenic SNAP29 variant. These variants are typically frameshift or nonsense mutations that introduce premature stop codons and yield truncated proteins or trigger nonsense‑mediated mRNA decay.[3][5][10][11] For example, the original c.220delG mutation described by Sprecher et al. leads to premature termination 27 amino acids downstream of the deletion, and immunohistochemistry in patient skin showed markedly decreased SNAP29 expression.[11][12] The South‑Indian case with c.486_487insA similarly displayed a frameshift and early termination; this variant had been previously reported in Pakistani patients and functionally validated as pathogenic.[5] The Iranian case with c.487dupA (p.A162fs) confirmed that different truncating variants in exon 3 can produce the same clinical syndrome.[10]

Most reported mutations are in the coding region and produce complete or near‑complete loss of protein function, consistent with a loss‑of‑function (LoF) mechanism.[3][4][10][11][12] ClinVar documents additional SNAP29 variants with CEDNIK association, but many are classified as variants of uncertain significance (VUS), such as c.-76G>A in the 5’ UTR, reflecting the limited number of patients and the difficulty of correlating noncoding variants with phenotype.[17] Population databases such as gnomAD generally show extremely low allele frequencies for LoF SNAP29 variants, which is expected given the severe, early‑onset phenotype; however, detailed frequency data are not reported in the accessible summaries for CEDNIK.[3][14][17] No susceptibility or “modifier” loci outside SNAP29 have been clearly identified; the small number of cases and uniform severity make detection of modifier genes challenging.

The question of genetic modifiers arises particularly in relation to variable penetrance of dermatologic and peripheral neuropathy features. Malacards notes that several authors have observed “that the dermatologic features and peripheral neuropathy show reduced penetrance and are more variable manifestations of this disorder, as they are not observed in all patients with biallelic SNAP29 mutations.”[14] This suggests that genetic background may modulate the expressivity of skin and peripheral nerve manifestations, perhaps through variation in other SNAREs, trafficking proteins, or keratinocyte‑specific pathways. However, to date no specific modifier genes have been robustly associated with CEDNIK, and the observed variability could also reflect environmental influences or stochastic developmental effects.[9][14][15]

2.3 Environmental and Lifestyle Risk Factors

Available evidence does not support a primary environmental, toxic, infectious, or lifestyle cause for CEDNIK syndrome. The disease arises from germline variants in SNAP29 present from conception and leads to congenital or very early‑onset manifestations.[3][4][11] Reports do not implicate prenatal exposures, maternal illness, or environmental toxins as etiologic factors, and the clustering of cases in consanguineous families strongly argues for genetic causation.[11][5][10][9] One patient‑oriented resource suggests that environmental factors or exposures during embryonic development “may also contribute to the development of CEDNIK syndrome,” but this statement appears speculative and is not supported by primary genetic or mechanistic literature.[8]

Lifestyle factors such as smoking, diet, and exercise have no documented influence on disease risk, onset, or severity, which is typical for severe early‑onset autosomal recessive neurodevelopmental disorders. Clinical reports describe affected infants and young children across diverse environments, with the common denominator being consanguinity and shared genetic variants rather than shared exposures.[5][10][11][15] Nonetheless, once the disease is established, environmental factors may modulate the course of complications: for example, recurrent aspiration pneumonia is a common cause of death, and exposure to respiratory pathogens or inadequate access to respiratory support could influence survival.[13][14][15] These are complications rather than etiologic risk factors.

2.4 Protective Factors

There are no known genetic protective variants that mitigate the risk of CEDNIK syndrome in individuals who carry biallelic pathogenic SNAP29 variants. Heterozygous carriers, including parents and siblings of affected individuals, are consistently reported as clinically unaffected, indicating that a single functional copy of SNAP29 is sufficient for normal development and represents the “protective” state.[3][5][10][11] This aligns with the autosomal recessive inheritance pattern and loss‑of‑function mechanism: full disease manifests only when both alleles are inactivated, whereas carriers retain adequate SNAP29 activity for vesicle fusion processes.[3][4][9][12]

Environmental or lifestyle protective factors have likewise not been formally identified. Supportive care, including aggressive management of feeding difficulties, respiratory infections, and skin barrier defects, may improve quality of life and potentially extend survival, but these interventions do not prevent disease onset or reverse underlying pathology.[4][13][15] Therefore, the most meaningful “protective” strategies exist at the level of reproductive risk management and genetic counseling, where carrier screening, prenatal diagnosis, and preimplantation genetic testing can prevent recurrence of CEDNIK in high‑risk families; these are discussed under prevention.[3][4][17]

2.5 Gene–Environment Interactions

Given the monogenic, fully penetrant nature of CEDNIK syndrome and its very early onset, gene–environment interactions have not been systematically explored and are likely to play a minor role in disease causation. The initiating lesion—a biallelic loss‑of‑function SNAP29 variant—occurs in the germline and disrupts vesicle trafficking in embryonic and fetal development.[11][12][16] The downstream consequences, including cerebral dysgenesis and abnormal epidermal differentiation, are established before birth or in early infancy, and environmental factors cannot reverse these developmental malformations.[3][4][13]

However, environmental factors may intersect with disease mechanisms in secondary ways. For example, defective lamellar granule secretion leads to a compromised epidermal barrier, making patients more susceptible to irritants, infections, and dehydration, which in turn can exacerbate ichthyosis and keratoderma.[11][12][15] Similarly, neurologic impairment predisposes to aspiration and respiratory infections, so exposure to pathogens and access to health care influence the severity of complications.[13][14][15] These interactions involve disease exacerbation rather than root‑cause gene–environment interplay. In terms of ontology, one could annotate CEDNIK as primarily MONDO:0012290 (genetic disease) with secondary environmental modifiers in the course of complications, but not as a gene–environment disorder in the classical sense.

3. Phenotypic Spectrum and Clinical Manifestations

3.1 Overview of Phenotypic Domains

CEDNIK syndrome manifests across multiple organ systems, with dominant involvement of the central nervous system, peripheral nervous system, skin, and sensory organs. OMIM and Malacards summarize the clinical picture as global developmental delay with hypotonia, roving eye movements or nystagmus, poor motor skills, and impaired intellectual development with speech delay, accompanied by microcephaly, feeding difficulties, seizures, ocular anomalies, hearing loss, facial dysmorphism, palmoplantar keratoderma, late‑onset ichthyosis, and peripheral neuropathy.[3][14] Orphanet emphasizes severe developmental abnormalities of the nervous system and aberrant epidermal differentiation.[6] A review of neuro‑ichthyotic syndromes notes that during the first four months of life, CEDNIK patients display roving eye movements, poor head and trunk control, microcephaly, facial dysmorphism, and failure to thrive; later in the first year, ichthyosis and palmoplantar keratoderma emerge.[13] Dermatologic case series confirm that ichthyosis and keratoderma are highly prevalent, with 100% and 85% frequencies respectively among reported patients.[15]

From an HPO perspective, key phenotypes include global developmental delay (HP:0001263), severe intellectual disability (HP:0002342), muscular hypotonia (HP:0001252), microcephaly (HP:0000252), cerebral dysgenesis (HP:0007113), agenesis or hypoplasia of the corpus callosum (HP:0001274), cortical dysplasia (HP:0002539), hypomyelination (HP:0003439), white matter loss (HP:0002500), ichthyosis (HP:0008064), palmoplantar keratoderma (HP:0007556), peripheral neuropathy (HP:0009830), sensorineural hearing loss (HP:0000407), visual impairment (HP:0000505), and failure to thrive (HP:0001508).[3][4][13][14][15] The syndrome’s impact on quality of life is profound: most patients exhibit severe motor and cognitive impairment, are unable to walk or speak meaningfully, and require extensive care for feeding, mobility, and skin management.[4][13][15] Below, phenotypes are organized by system, with attention to age of onset, severity, progression, and frequency.

3.2 Neurologic and Developmental Phenotypes

Neurologic and developmental manifestations constitute the core of CEDNIK syndrome and are apparent from early infancy. Global developmental delay (HP:0001263) and severe psychomotor retardation are universal features, described in all major series and case reports.[3][4][5][10][11][14][15] Sprecher et al. reported “severe psychomotor retardation” and “intellectual impairment” in all affected children, with delayed or absent milestones such as head control, sitting, and walking.[11] The Indian case report notes “severe psychomotor retardation, failure to thrive, progressive microcephaly,” and poor motor skills.[5] Mah‑Som et al. observed global developmental delay with hypotonia and impaired intellectual development in their cohort, consistent with the classical description.[9][14]

Hypotonia (HP:0001252) is prominent, often noted in the first months of life. Neuro‑ichthyotic reviews describe CEDNIK infants with poor head and trunk control, generalized hypotonia, and areflexia, reflecting combined central and peripheral involvement.[13][15] Peripheral neuropathy (HP:0009830), manifesting as areflexia, distal weakness, and sometimes sensory loss, has been reported in many but not all patients, leading to the conclusion that neuropathy shows reduced penetrance.[3][9][14][15] Sensorimotor neuropathy may be detected by nerve conduction studies, but detailed electrophysiologic data are sparse in the literature.[5][10]

Microcephaly (HP:0000252) is a frequent and often progressive feature, with head circumference falling behind normative curves over time.[5][10][13][14] Radiologic studies reveal cerebral dysgenesis (HP:0007113), including absent or thin corpus callosum (HP:0001274), cortical dysplasia with pachygyria or polymicrogyria (HP:0002539), and hypomyelination or white matter loss (HP:0003439; HP:0002500).[5][9][10][13][14] The Indian case documented brainstem malformation as a novel imaging finding, suggesting that posterior fossa structures may also be affected.[5] Neurology Genetics reports underline frequent corpus callosum abnormalities and cortical malformations consistent with a developmental brain dysgenesis pattern.[9]

Seizures (HP:0001250) are variably reported. Malacards lists seizures among possible features, and the dermatologic series notes that some patients exhibit epilepsy.[14][15] However, seizures are not universal; their frequency cannot be precisely estimated due to small numbers, but they likely occur in a substantial minority. Roving eye movements and nystagmus (HP:0000518) in early infancy are characteristic and sometimes precede overt cortical visual impairment.[3][13][14] Intellectual disability is severe, with speech often absent or extremely limited; many patients remain nonverbal throughout life.[4][11][15]

The progression of neurologic disability is generally progressive rather than static. Neuro‑ichthyotic reviews and case reports describe worsening microcephaly, increasing contractures, and decline in functional abilities over time.[5][13][14] Developmental regression has been observed in some patients, likely reflecting neurodegenerative processes superimposed on a dysgenetic brain.[14][15] Quality of life impact is immense: affected children rarely achieve independent ambulation, often require gastrostomy or assisted feeding, and display limited purposeful interaction with their environment.[4][13][15] From a brain ontology standpoint, affected structures include the cerebral cortex (UBERON:0000956), corpus callosum (UBERON:0002315), white matter (UBERON:0002439), and brainstem (UBERON:0002038).[5][9][10]

3.3 Cutaneous Phenotypes: Ichthyosis and Keratoderma

Cutaneous manifestations are defining features of CEDNIK and relate directly to SNAP29’s role in lamellar granule maturation and epidermal lipid trafficking.[11][12][15] Ichthyosis (HP:0008064) is described in nearly all patients, though the age of onset may vary. Sprecher et al. noted generalized scaling and ichthyosiform erythroderma, with histologic evidence of retention hyperkeratosis.[11][12] Neuro‑ichthyotic reviews state that ichthyosis and palmoplantar keratoderma generally appear later in the first year of life, after neurologic features are already evident.[13] Orphanet and GARD list ichthyosis and palmoplantar keratoderma as core components of the syndrome.[1][6]

A recent dermatologic series provides the most robust data on cutaneous phenotype frequency. Among 20 patients with genetically confirmed CEDNIK syndrome, all (100%) exhibited ichthyosis, and 17 (85%) had keratoderma affecting palms, soles, or both.[15] The authors conclude that “keratoderma and ichthyosis [are] valuable features for the diagnosis of CEDNIK syndrome,” emphasizing their utility as diagnostic clues in the context of neurologic impairment.[15] Palmoplantar keratoderma (PPK; HP:0007556) may present as diffuse thickening of palmar and plantar skin, often with fissuring, leading to pain, difficulty walking, and impaired manual function.[5][13][15] Retention hyperkeratosis, due to incomplete desquamation, is a characteristic histologic finding.[11][12][15]

At the cellular level, lamellar granules in the upper epidermis are responsible for delivering lipids, proteases, and protease inhibitors to the stratum corneum, critical for barrier formation.[2][11][12][15] SNAP29 deficiency leads to abnormal maturation and secretion of these granules, resulting in mislocation and retention of glucosylceramide and kallikrein‑containing granules in the stratum corneum.[11][12][15] This causes defective barrier formation and retention hyperkeratosis, explaining the ichthyosiform phenotype and keratoderma.[12][15] In vitro models replicating SNAP29 deficiency in keratinocytes reproduce the ichthyotic phenotype, reinforcing the mechanistic link.[15][12]

The impact of skin disease on quality of life is considerable. Patients may experience itching, fissuring, pain, and increased susceptibility to infections due to barrier compromise.[11][15] PPK can limit mobility and manual dexterity, further compounding neurologic disability.[13][15] Dermatologic care requires regular emollients, keratolytics, and sometimes topical anti‑inflammatory agents; however, no disease‑specific therapy exists.[4][5][15] HPO terms such as HP:0008064 (ichthyosis), HP:0007556 (palmoplantar keratoderma), HP:0000988 (xerosis cutis), and HP:0000999 (hyperkeratosis) are appropriate for annotation.[13][15]

3.4 Craniofacial and Growth Phenotypes

CEDNIK patients often have distinctive facial features and growth abnormalities. Neuro‑ichthyotic reviews describe elongated faces, antimongolian eye slant, mild hypertelorism, and a flat broad nasal root, contributing to a recognizable facial gestalt.[13] Malacards adds nonspecific dysmorphic facial features, including synophrys, long eyelashes, flaring nares, and depressed nasal bridge.[14][15] These features map to HPO terms such as HP:0000268 (facial dysmorphism), HP:0000316 (hypertelorism), HP:0000280 (synophrys), HP:0000427 (epicanthal folds), and HP:0000444 (depressed nasal bridge).[13][14][15]

Failure to thrive (HP:0001508) is common, with poor weight gain and short stature relative to age norms.[5][13][14][15] Feeding difficulties (HP:0001955), including weak suck, swallowing dysfunction, and aspiration, contribute to malnutrition and recurrent respiratory infections.[13][14][15] One dermatologic series notes aspiration pneumonia as a common cause of death between ages 5 and 12 years.[15] Microcephaly (HP:0000252) has already been discussed, but it is part of the overall growth phenotype. Many patients appear small and frail, with limited subcutaneous fat and muscle mass, reflecting chronic illness and nutritional compromise.[4][5][13]

The quality‑of‑life impact of growth and craniofacial abnormalities is intertwined with neurologic and dermatologic disability. Feeding challenges necessitate specialized support such as thickened feeds, nasogastric or gastrostomy tubes, and intensive caregiver vigilance to prevent aspiration.[4][13] Facial dysmorphism can contribute to social stigma, although most patients have such severe neurologic impairment that social participation is minimal. From an anatomical ontology perspective, relevant structures include the craniofacial region (UBERON:0000160), nasal bridge (UBERON:0001687), and orbit (UBERON:0000970).[13][14]

3.5 Sensory Phenotypes: Ocular and Auditory Involvement

CEDNIK syndrome often involves sensory systems, particularly vision and hearing. Neuro‑ichthyotic reviews note that visual impairment is common, with optic nerve abnormalities, macular atrophy, and cortical visual impairment contributing to poor visual function.[13][14] Malacards lists ocular anomalies and optic nerve hypoplasia among variable features.[14] Roving eye movements and nystagmus in early infancy likely reflect both brainstem and cortical involvement and are often accompanied by poor visual tracking.[3][13][15] HPO terms such as HP:0000505 (visual impairment), HP:0000546 (nystagmus), and HP:0000579 (optic nerve hypoplasia) are applicable.

Sensorineural hearing loss (HP:0000407) has been reported in several patients.[5][13][14][15] The Indian case report explicitly mentions “sensori‑neural hearing loss” as part of the clinical picture, and neuro‑ichthyotic reviews note that deafness is a “primary neurologic manifestation” in related neuro‑ichthyotic disorders, including CEDNIK.[5][13] However, hearing loss is not universal; some patients have normal hearing, indicating variable expressivity.[9][14][15] The pathophysiology likely involves both cochlear and central auditory pathways, but detailed audiometric and neurophysiologic data are lacking.

The impact of sensory impairment on quality of life is significant. Visual and auditory deficits further limit communication and environmental engagement in children already burdened by severe cognitive and motor disabilities.[4][13][15] Caregivers must rely heavily on tactile and auditory cues when possible, and sensory impairments complicate rehabilitation efforts. From an anatomical standpoint, relevant structures include the optic nerve (UBERON:0001614), retina (UBERON:0000956), cochlea (UBERON:0001844), and auditory cortex (UBERON:0001890).[13][14]

3.6 Behavioral and Neuropsychiatric Phenotypes

Although most CEDNIK patients have severe intellectual disability limiting complex behavioral assessments, some reports describe neurobehavioral features such as repetitive behaviors and purposeless movements.[15][14] The dermatologic series mentions repetitive behavior and purposeless movements among the spectrum of additional manifestations, consistent with subcortical or cortical dysfunction.[15] These could map to HPO terms HP:0000733 (stereotypy) and HP:0000736 (abnormal behavior). However, detailed psychiatric evaluation is rarely possible due to profound cognitive impairment, and no formal diagnoses under DSM or RDoC frameworks have been reported.

Sleep disturbances, irritability, and autonomic dysregulation may occur but are not systematically described.[4][13][15] Quality‑of‑life instruments such as EQ‑5D or SF‑36 have not been applied to CEDNIK, and neuropsychiatric symptoms are generally subsumed within the broader category of severe neurodevelopmental disorder. Nonetheless, annotation of behavioral features, when present, is valuable for understanding the full spectrum and for distinguishing CEDNIK from other neuro‑ichthyoses that may have more prominent behavioral phenotypes.[13]

4. Genetic and Molecular Information

4.1 Causal Gene: SNAP29 (Synaptosomal‑Associated Protein 29)

The causal gene for CEDNIK syndrome is SNAP29, encoding synaptosomal‑associated protein 29, a member of the SNAP‑25 family of SNARE proteins.[3][11][16] SNAP29 is located on chromosome 22q11.21–22q11.2, within a region that is also implicated in 22q11 deletion syndrome but distinct in its phenotypic consequences when mutated biallelically.[3][11][16] OMIM lists SNAP29 under MIM 604202, paired with the CEDNIK phenotype 609528.[3] HGNC (HUGO Gene Nomenclature Committee) designates SNAP29 as HGNC:11186, and NCBI Gene provides detailed sequence and functional annotations.[16][3]

SNAP29 is a SNARE protein that participates in intracellular membrane fusion, functioning in multiple pathways including exocytosis, endocytosis, autophagy, and ciliogenesis.[9][12][16] JensenLab’s DISEASES database notes that “SNAP29 is a SNARE involved in autophagy through the direct control of autophagosome membrane fusion with the lysosome membrane” and “plays also a role in ciliogenesis by regulating membrane fusions; belongs to the SNAP‑25 family.”[16] In neurons, SNAP29 acts as a negative modulator of synaptic vesicle turnover by slowing the recycling of the SNARE complex and synaptic vesicles.[12] In keratinocytes, SNAP29 is critical for lamellar granule maturation and secretion, which underlie the epidermal barrier formation.[11][12][15]

4.2 Pathogenic Variants: Types, Locations, and Functional Consequences

Pathogenic variants in SNAP29 causing CEDNIK are predominantly truncating loss‑of‑function mutations, including frameshift insertions and deletions. Sprecher et al. identified a homozygous 1‑bp deletion c.220delG in exon 1, which caused a frameshift and premature termination 27 amino acids downstream; this variant resulted in complete absence of SNAP29 protein in patient skin.[11][12] Immunohistochemistry showed decreased SNAP29 expression, and ultrastructural studies revealed abnormal lamellar granule maturation and secretion.[11][12] In the Indian case, clinical exome sequencing uncovered a homozygous single base pair insertion in exon 3 (c.486_487insA), leading to a frameshift and premature termination (p.Ser163LysfsTer6); this variant had previously been reported in Pakistani children and functionally established as pathogenic.[5] The Iranian case reported a homozygous duplication c.487dupA (p.A162fs) in exon 3, confirming that different frameshift variants in this region can produce CEDNIK.[10]

Mah‑Som et al.’s Neurology Genetics cohort described multiple distinct biallelic SNAP29 variants, including frameshift, nonsense, and splice‑site mutations, all predicted to result in loss of function.[9][14] These variants were absent or extremely rare in population databases, supporting their pathogenicity.[9] ClinVar, while listing many SNAP29 variants, includes only a subset with CEDNIK association; for example, NM_004782.4(SNAP29):c.-76G>A is classified as a variant of uncertain significance for CEDNIK syndrome, highlighting the challenge of interpreting noncoding changes.[17]

Functional studies provide strong evidence that CEDNIK is a loss‑of‑function disease. In fibroblasts derived from CEDNIK patients, SNAP29 deficiency impaired endocytic recycling of transferrin and β1‑integrin and altered Golgi morphology, while exocytosis from the Golgi apparatus remained largely intact.[12] Overexpression of SNAP29 in presynaptic neurons inhibited synaptic transmission by slowing SNARE complex disassembly, whereas knockdown increased synaptic efficiency, indicating that physiological SNAP29 levels modulate vesicle turnover.[12] Thus, complete loss of SNAP29 disrupts multiple trafficking pathways, with cell type‑specific consequences.

4.3 Allele Frequency, Somatic versus Germline Origin

CEDNIK‑associated SNAP29 variants are germline mutations present in all cells of affected individuals. There is no evidence of somatic mosaicism or acquired mutations contributing to the syndrome.[3][4][9][11] All reported patients have consanguineous or nonconsanguineous parents who are heterozygous carriers of the pathogenic variant, consistent with autosomal recessive inheritance.[3][5][10][11] The transmission pattern in Mah‑Som et al.’s cohort was consistent with autosomal recessive inheritance across families.[3][9]

Population allele frequencies are extremely low. Although detailed gnomAD data are not included in the accessible summaries, the rarity of reported patients and the highly deleterious nature of LoF SNAP29 variants suggest strong negative selection against homozygosity.[3][14][17] The presence of multiple distinct truncating variants across unrelated families indicates that CEDNIK arises from private or family‑specific mutations rather than a common founder allele, although the original Arab families may share a founder c.220delG mutation.[11][3][10] Somatic alterations of SNAP29 have been studied in cancer and other contexts, but these are unrelated to CEDNIK’s germline etiology.[16]

4.4 Modifier Genes and Epigenetic Information

To date, no specific modifier genes have been identified that alter the severity or expression of CEDNIK syndrome. As noted earlier, variability in dermatologic and neuropathic features suggests possible genetic or epigenetic modulation, but the small number of patients and lack of systematic genome‑wide analyses preclude firm conclusions.[9][14][15] Epigenetic regulation of SNAP29 has been studied in other contexts, but there is no direct evidence of epigenetic changes contributing to CEDNIK pathogenesis beyond the primary loss‑of‑function variants.[16]

Databases such as ENCODE and Roadmap Epigenomics provide general epigenetic profiles of the SNAP29 locus (e.g., chromatin state, methylation), but these have not been linked to CEDNIK specifically in primary literature.[16] Thus, epigenetic information is currently not available or not directly relevant for this disease. Future studies could explore whether epigenetic modifications of other trafficking genes modulate phenotype in SNAP29‑null individuals, but this remains speculative.

4.5 Chromosomal Abnormalities and Structural Genomics

CEDNIK has not been associated with large‑scale chromosomal abnormalities such as aneuploidy, translocations, or microdeletions in published reports. Homozygosity mapping and exome sequencing have consistently pointed to localized SNAP29 mutations in an otherwise structurally normal chromosome 22.[3][11][9][10] This is noteworthy because the SNAP29 locus resides within the 22q11 region, where deletions cause DiGeorge/velocardiofacial syndrome; however, those heterozygous deletions do not produce CEDNIK‑like phenotypes, and no combination of 22q11 deletion with a second SNAP29 hit has been reported.[3][11][16]

Whole‑exome sequencing appears sufficient to detect the majority of pathogenic SNAP29 variants, given that they are primarily small coding changes.[4][5][9][10] Structural genomic features such as local chromatin organization, regulatory elements, and copy number variation at the SNAP29 locus have not been extensively studied in relation to CEDNIK, and DECIPHER or dbVar do not list recurrent structural variants causing the syndrome.[3][10][17] Therefore, in the current knowledge base, CEDNIK is a point‑mutation–driven monogenic disorder rather than a structural genomic syndrome.

5. Environmental Information

5.1 Non‑Genetic Contributing Factors

As discussed under etiology, non‑genetic contributing factors (toxins, radiation, pollution, occupational exposures) have not been implicated in causing CEDNIK syndrome. The disorder arises from germline mutations present from conception, and its manifestations are evident in early infancy irrespective of external exposures.[3][4][11] No CTD or TOXNET entries link specific environmental chemicals to CEDNIK, and case reports do not describe common exposures among affected families beyond consanguinity.[5][10][11]

That said, environmental factors can influence the course of complications. The compromised skin barrier due to ichthyosis and keratoderma increases susceptibility to irritants, infections, and dehydration, and environmental conditions such as climate and hygiene may modulate skin symptom severity.[11][15] Likewise, neurologic impairment predisposes to respiratory infections and aspiration; health care access, nutrition, and infection control may influence morbidity and mortality.[13][14][15] These influences are downstream and do not constitute etiologic risk factors for disease development.

5.2 Lifestyle Factors and Infectious Agents

Lifestyle factors—smoking, alcohol, diet, exercise—are not relevant to disease causation given the early onset and severe developmental impairment in CEDNIK.[3][4][13] Caregivers may modify diet and positioning to mitigate aspiration risk and improve nutrition, but these measures are therapeutic rather than etiologic. Infectious agents do not cause CEDNIK but often contribute to mortality as complications, particularly aspiration pneumonia.[13][14][15] A dermatologic series notes that “a common cause of death mentioned in prior cases of patients with the characteristic features of CEDNIK syndrome is aspiration pneumonia between the ages of 5 and 12 years.”[15] Thus, while pathogens such as respiratory bacteria and viruses may trigger fatal events, they act on a vulnerable host already compromised by CEDNIK.

Overall, environmental and lifestyle factors in CEDNIK are best conceptualized as modulators of symptom burden and complication risk rather than etiologic contributors. This distinction is important for ontology and risk modeling: CEDNIK remains a Mendelian disorder (MONDO:0012290), with secondary environmental interactions at the level of comorbidity management.

6. Mechanisms and Pathophysiology

6.1 Ordered Causal Chain from Mutation to Clinical Phenotype

The pathophysiology of CEDNIK syndrome can be described as a series of causal steps, each leading to the next, from the initiating genetic lesion to the observable clinical features:

Step 1 – Biallelic loss‑of‑function mutation in the SNAP29 gene leads to complete or near‑complete absence of SNAP29 protein in patient cells.[3][11][12]

Step 2 – Loss of SNAP29 results in impaired SNARE‑mediated membrane fusion in multiple intracellular trafficking pathways, including endocytosis, autophagy, lamellar granule maturation, and ciliogenesis.[9][12][16]

Step 3 – In epidermal keratinocytes, defective lamellar granule maturation and secretion leads to mislocation and retention of epidermal lipids (e.g., glucosylceramide) and proteases (e.g., kallikreins) in the stratum corneum, resulting in retention hyperkeratosis and defective skin barrier formation, which manifests clinically as generalized ichthyosis and palmoplantar keratoderma.[11][12][15]

Step 4 – In neurons and glial cells, impaired vesicle trafficking, including defective endocytic recycling of cell surface receptors and altered autophagosome–lysosome fusion, leads to abnormal synaptic transmission, disrupted neuronal polarity, and impaired myelination, resulting in cerebral dysgenesis, white matter loss, and peripheral neuropathy.[9][12][13][14]

Step 5 – Cerebral dysgenesis, including agenesis or hypoplasia of the corpus callosum and cortical dysplasia, leads to global developmental delay, intellectual disability, microcephaly, hypotonia, and roving eye movements.[3][5][9][13][14]

Step 6 – Peripheral neuropathy and neuromuscular involvement result in hypotonia, distal weakness, areflexia, and poor motor skills, further contributing to severe psychomotor retardation.[3][5][9][14][15]

Step 7 – Defective epidermal barrier and neurologic impairment lead to secondary complications such as infections, aspiration, and failure to thrive, which together result in high childhood mortality, often due to aspiration pneumonia.[13][14][15]

Some steps, particularly the detailed mechanisms linking SNAP29 loss to specific brain malformations and neuropathy, are inferred from general SNARE biology and in vitro studies rather than directly demonstrated in human brain tissue; however, the overall chain is strongly supported by combined clinical, genetic, and mechanistic data.[9][11][12][15][16]

6.2 Molecular Pathways: SNARE‑Mediated Trafficking, Autophagy, and Ciliogenesis

SNAP29 functions within the broader SNARE (soluble N‑ethylmaleimide‑sensitive factor attachment protein receptor) machinery, which mediates membrane fusion events essential for vesicle trafficking.[9][12][16] As a t‑SNARE, SNAP29 interacts with other SNAREs and accessory proteins to regulate both exocytosis and endocytosis. Levy et al., in “Loss of SNAP29 Impairs Endocytic Recycling and Cell Motility,” demonstrated that SNAP29 mediates endocytic recycling of transferrin and β1‑integrin in fibroblasts derived from CEDNIK patients.[12] They showed that loss of functional SNAP29 leads to intracellular accumulation of these cargoes and retarded cell motility, indicating a key role in clathrin‑dependent and clathrin‑independent endocytic recycling.[12]

SNAP29 also participates in autophagy. JensenLab notes that “SNAP29 is a SNARE involved in autophagy through the direct control of autophagosome membrane fusion with the lysosome membrane.”[16] In this context, SNAP29 forms complexes with other SNAREs to mediate fusion of autophagosomes with lysosomes, allowing degradation of cytoplasmic cargo. Loss of SNAP29 would be expected to impair autophagic flux, leading to accumulation of damaged organelles and proteins, which can contribute to neurodegeneration.[9][12][16] Furthermore, SNAP29 plays a role in ciliogenesis by regulating membrane fusions necessary for primary cilium formation, suggesting that ciliary signaling pathways may be perturbed in CEDNIK.[9][16]

In neurons, overexpression and knockdown studies indicate that SNAP29 acts as a negative modulator of synaptic transmission. Levy et al. reported that overexpression of SNAP29 in presynaptic neurons inhibited synaptic transmission by slowing recycling of the SNARE complex and synaptic vesicle turnover, whereas RNAi‑mediated knockdown increased synaptic efficiency.[12] They concluded that “SNAP29 acts as a negative modulator for neurotransmitter release, probably by slowing recycling of the SNARE based fusion machinery and synaptic vesicle turnover.”[12] In CEDNIK patients, complete loss of SNAP29 may disrupt balanced synaptic regulation and impair development of proper neuronal circuits.

6.3 Cellular Processes: Endocytosis, Recycling, Autophagy, and Epidermal Differentiation

At the cellular level, several processes are disrupted in CEDNIK syndrome. In fibroblasts from CEDNIK patients, Levy et al. observed impaired endocytic recycling of transferrin and β1‑integrin, affecting cell motility and spreading.[12] They noted that “while exocytosis of VSVG protein was not affected, endocytic recycling of transferrin and β1‑integrin was impaired in CEDNIK cells, affecting cell motility and migration.”[12] This suggests that SNAP29’s role in exocytosis is limited or redundant, whereas its role in endocytic recycling is critical. GO biological process terms such as GO:0006897 (endocytosis), GO:0006898 (receptor‑mediated endocytosis), GO:0016192 (vesicle‑mediated transport), and GO:0006914 (autophagy) are directly relevant.

In keratinocytes, SNAP29 deficiency prevents maturation and secretion of lamellar granules, which are Golgi‑derived vesicles transporting lipids and proteases to the upper epidermal layers.[11][12][15] Sprecher et al. showed that “SNAP29 expression was decreased in the skin of the patients, resulting in abnormal maturation of lamellar granules and, as a consequence, in mislocation of epidermal lipids and proteases.”[11] They concluded that these data “underscore the importance of vesicle trafficking regulatory mechanisms for proper neuroectodermal differentiation.”[11] Levy et al. further emphasized that “SNAP29 deficiency was found to prevent both the maturation and the secretion of lamellar granules,” leading to retention of glucosylceramide and kallikrein‑containing granules in the stratum corneum.[12][15] GO terms such as GO:0001533 (cornified envelope), GO:0008544 (epidermis development), and GO:0048812 (epidermal cell differentiation) capture these processes.

Autophagy is likely impaired in multiple cell types, including neurons and glia, contributing to neurodegeneration. SNAP29’s role in autophagosome–lysosome fusion is captured by GO:0006914 (autophagy) and GO:0000422 (autophagy of mitochondrion), although specific autophagic defects in CEDNIK neurons have not been directly documented.[9][12][16] Ciliogenesis defects may alter signaling pathways crucial for neurodevelopment; GO terms such as GO:0030992 (intraciliary transport) and GO:0036064 (cilium organization) are relevant.[9][16]

6.4 Protein Dysfunction: Loss‑of‑Function SNARE Defect

CEDNIK is a paradigmatic loss‑of‑function SNARE disorder. Frameshift and nonsense mutations in SNAP29 lead to truncated, nonfunctional proteins or absence of protein due to nonsense‑mediated decay.[3][5][10][11][12] Sprecher et al. reported complete absence of SNAP29 protein in patient skin and attributed the CEDNIK phenotype to the resulting defect in lamellar granule maturation.[11] Levy et al. expanded this view by showing that SNAP29 loss in fibroblasts affects endocytic recycling and cell motility without major changes in exocytosis, highlighting cell type‑specific effects.[12]

The functional consequences of SNAP29 loss can be conceptualized as failure of SNARE complex assembly or disassembly at specific membrane interfaces. Normally, SNAP29 interacts with other SNAREs such as syntaxin and VAMP family members to form a complex that mediates vesicle docking and fusion.[12][16] Loss of SNAP29 disrupts this complex, preventing efficient fusion of endosomes with recycling compartments, autophagosomes with lysosomes, and lamellar granules with the plasma membrane.[12][16] This protein dysfunction underlies both neurodevelopmental and epidermal phenotypes. In ontological terms, SNAP29 is annotated to GO:0005484 (SNARE binding), GO:0005515 (protein binding), and GO:0016192 (vesicle‑mediated transport).[16]

6.5 Metabolic and Biochemical Abnormalities

Metabolic and biochemical abnormalities in CEDNIK are most clearly documented in the epidermis. Retained glucosylceramide and kallikrein‑containing granules in the stratum corneum reflect disruption of lipid and protease trafficking.[12][15] Glucosylceramide (CHEBI:37739) is a key lipid component in epidermal barrier formation, and kallikreins are serine proteases involved in desquamation.[15] Retention of these molecules leads to defective barrier formation and hyperkeratosis, consistent with the ichthyosiform phenotype.[11][12][15] While precise metabolomic signatures have not been described, one can infer perturbations in lipid metabolism and protease activity in keratinocytes.

In the nervous system, metabolic consequences of SNAP29 loss have not been directly profiled via metabolomics. However, given the role of autophagy in cellular energy homeostasis and clearance of damaged organelles, impaired autophagy may lead to accumulation of toxic metabolites and oxidative stress, contributing to neurodegeneration.[9][12][16] No specific enzyme deficiencies, receptor dysfunctions, or ion channel defects beyond SNARE dysfunction have been reported. Biochemical tests in patients generally focus on ruling out other causes of neuro‑ichthyosis, such as lipid storage disorders or peroxisomal diseases, and are typically normal.[13][4]

6.6 Immune System Involvement and Tissue Damage Mechanisms

Direct immune system involvement—autoimmunity, immunodeficiency—has not been reported as a primary feature of CEDNIK. However, defective skin barrier function predisposes to recurrent skin infections and inflammation, and aspiration pneumonia often leads to systemic inflammatory responses and respiratory failure.[13][14][15] Tissue damage mechanisms in CEDNIK thus include chronic mechanical stress and fissuring of hyperkeratotic skin, secondary infection, and neurodegenerative processes in the central and peripheral nervous system.

In the nervous system, tissue injury likely arises from a combination of developmental malformations (improper cortical layering, corpus callosum agenesis) and progressive degeneration due to autophagy defects and trafficking abnormalities.[9][12][13] White matter loss suggests demyelination or hypomyelination, which could involve oligodendrocyte dysfunction and axonal degeneration.[9][10][14] Oxidative stress, mitochondrial dysfunction, and apoptotic pathways may be involved but have not been directly demonstrated in CEDNIK brain tissue; these mechanisms are inferred from general autophagy and SNARE biology.[9][12][16]

6.7 Molecular Profiling and Advanced Technologies

To date, no disease‑specific transcriptomic, proteomic, metabolomic, or lipidomic profiling has been published for CEDNIK beyond targeted studies of SNAP29 function in fibroblasts and keratinocytes.[12][11][15] GEO and related databases may contain datasets involving SNAP29 knockdown or overexpression in model systems, but these are not annotated explicitly as CEDNIK.[16] Single‑cell analysis, spatial transcriptomics, multi‑omics integration, and CRISPR/RNAi functional genomics screens have been applied to SNARE biology and autophagy more broadly, yet disease‑specific applications in CEDNIK remain unexplored.

Levy et al.’s fibroblast study, while not an omics survey, provides functional data that could be integrated with future proteomic or transcriptomic analyses.[12] For example, impaired β1‑integrin recycling suggests altered integrin signaling networks, which could be probed via phosphoproteomics. In keratinocytes, lamellar granule dysfunction could be studied via lipidomics to quantify changes in ceramide and glucosylceramide species.[15] However, until such studies are conducted, molecular profiling of CEDNIK must rely primarily on mechanistic experiments and inferred pathways from SNAP29 function.

6.8 Cell Types and Biological Processes: Ontology Suggestions

CEDNIK pathophysiology involves multiple cell types, which can be annotated with Cell Ontology (CL) terms. Key cell types include keratinocytes (CL:0000312), which exhibit lamellar granule maturation defects; fibroblasts (CL:0000057), used as in vitro models of SNAP29 deficiency; neurons (CL:0000540), subject to synaptic and trafficking abnormalities; oligodendrocytes (CL:0000128), likely affected given white matter loss and hypomyelination; and Schwann cells (CL:0002573), involved in peripheral neuropathy.[11][12][13][14][15] Biological processes can be mapped to GO terms such as GO:0016192 (vesicle‑mediated transport), GO:0006914 (autophagy), GO:0006897 (endocytosis), GO:0008544 (epidermis development), and GO:0007268 (synaptic transmission).[12][16]

By integrating CL and GO annotations with MONDO:0012290 (CEDNIK syndrome) and HGNC:11186 (SNAP29), a knowledge base can represent the multi‑cellular and multi‑process nature of the disease: a SNARE‑mediated vesicle trafficking disorder impacting neuroectodermal tissues, particularly keratinocytes and neurons, leading to neurocutaneous phenotypes.

7. Anatomical Structures Affected

7.1 Organ‑Level Involvement

CEDNIK syndrome primarily affects the central nervous system (CNS), peripheral nervous system (PNS), skin, and sensory organs, with secondary involvement of respiratory and gastrointestinal systems via complications. The CNS abnormalities include cerebral dysgenesis, corpus callosum agenesis or hypoplasia, cortical dysplasia, microcephaly, and white matter loss, implicating the cerebral cortex (UBERON:0000956), corpus callosum (UBERON:0002315), and white matter (UBERON:0002439).[5][9][10][13][14] Brainstem malformations have been reported in at least one case, involving the brainstem (UBERON:0002038).[5] Peripheral neuropathy indicates involvement of peripheral nerves (UBERON:0001037) and neuromuscular junctions.[3][5][9][14][15]

The skin is extensively involved, with generalized ichthyosis and palmoplantar keratoderma affecting the epidermis (UBERON:0001003) and dermis (UBERON:0001025), particularly the palmar (UBERON:0002397) and plantar (UBERON:0001514) surfaces.[11][12][15] Sensory organs include the eyes, with optic nerve and macular abnormalities (UBERON:0001614; UBERON:0000944), and ears, with cochlear and auditory pathway involvement in sensorineural hearing loss (UBERON:0001844; UBERON:0001890).[5][13][14][15]

Secondary organ involvement arises through complications. Respiratory compromise and aspiration pneumonia affect the lungs (UBERON:0002048) and airways.[13][14][15] Feeding difficulties and failure to thrive involve the esophagus (UBERON:0001043), stomach (UBERON:0000945), and oropharynx (UBERON:0001729), as well as the musculature controlling swallowing.[13][14] However, these organs are not primarily malformed by SNAP29 loss; they are functionally compromised by neurologic deficits.

7.2 Tissue and Cell‑Level Targets

At the tissue level, CEDNIK affects neural tissue, epidermal tissue, and connective tissue. Neural tissue is impacted in the cortex, white matter, brainstem, and peripheral nerves, with abnormalities in neuronal migration, axonal connectivity, and myelination.[5][9][10][13][14] Epidermal tissue exhibits hyperkeratosis, impaired barrier formation, and altered differentiation, particularly in the stratum corneum.[11][12][15] Connective tissue, including dermal fibroblasts, shows impaired cell motility due to integrin recycling defects.[12]

Cell types involved include keratinocytes (CL:0000312), neurons (CL:0000540), oligodendrocytes (CL:0000128), Schwann cells (CL:0002573), fibroblasts (CL:0000057), and potentially ependymal cells and radial glia during brain development, though these are inferred rather than directly documented.[11][12][13][14][15] In fibroblast models, SNAP29 loss impairs endocytic recycling and cell spreading, indicating that even non‑neuroectodermal cells rely on SNAP29 for proper motility.[12] In keratinocytes, lamellar granule maturation defects manifest as retention hyperkeratosis.[11][12][15] In neurons, altered synaptic vesicle recycling and autophagy likely disrupt network formation and maintenance.[12][16]

7.3 Subcellular Compartments

CEDNIK pathophysiology is fundamentally subcellular, involving defects in vesicle trafficking and organelle interaction. Key compartments include endosomes, recycling endosomes, lysosomes, Golgi apparatus, autophagosomes, and lamellar granules.[11][12][16] GO cellular component terms such as GO:0005768 (endosome), GO:0005783 (endoplasmic reticulum), GO:0005794 (Golgi apparatus), GO:0005773 (vacuole/lysosome), GO:0005776 (autophagic vacuole), and GO:0031017 (lamellar body) are directly relevant.

Levy et al. reported that SNAP29‑deficient cells exhibit dispersed Golgi morphology and impaired recycling of transferrin and integrins, indicating altered endosomal trafficking.[12] Sprecher et al. described abnormal lamellar granule maturation and secretion in the epidermis; these granules are specialized secretory organelles derived from the Golgi.[11] SNAP29’s role in autophagosome–lysosome fusion implicates autophagosomes and lysosomes as key compartments.[16] In cilia, SNAP29 regulates membrane fusion events necessary for ciliary formation, implicating the basal body and ciliary membrane.[16]

7.4 Localization and Lateralization

Anatomically, CEDNIK lesions are generally bilateral and symmetric, reflecting systemic genetic disturbance rather than focal acquired injury. Cerebral dysgenesis affects both hemispheres, corpus callosum, and cortical surfaces, often with widespread polymicrogyria or pachygyria.[5][9][10][13][14] White matter loss and hypomyelination are diffuse.[9][14] Peripheral neuropathy is typically length‑dependent and symmetric, affecting distal limbs.[3][5][9][14][15] Ichthyosis and keratoderma are generalized or symmetrically distributed, although PPK may vary somewhat in severity between hands and feet.[11][15]

No consistent lateralization patterns (e.g., left‑right asymmetry) have been reported in brain or skin findings. MRI studies focus on presence or absence of structures rather than lateralized lesion distribution.[5][9][10][13][14] Thus, from an ontology perspective, CEDNIK can be annotated as involving bilateral brain and skin structures, with symmetric peripheral neuropathy.

8. Temporal Development and Natural History

8.1 Age of Onset and Onset Pattern

CEDNIK syndrome has a congenital or very early pediatric onset. Neuro‑ichthyotic reviews emphasize that during the first four months of life, patients exhibit roving eye movements, poor head and trunk control, microcephaly, and failure to thrive.[13] OMIM and Malacards indicate onset in infancy or neonatal period, with developmental abnormalities evident soon after birth.[3][14] Orphanet notes that the disease is characterized by severe developmental abnormalities of the nervous system, consistent with prenatal onset.[6]

Cutaneous features typically appear slightly later. Ichthyosis and palmoplantar keratoderma most often emerge during the first year of life, sometimes after neurologic features have already led to diagnostic evaluation.[11][13][15] A dermatologic series reports that cutaneous findings “can present either in infancy or have a late onset presentation,” indicating some variability; however, most patients develop ichthyosis and keratoderma in early childhood.[15] Thus, the onset pattern can be described as chronic and insidious, with neurologic signs present from early infancy and skin signs emerging over months.

8.2 Disease Progression, Stages, and Rate

CEDNIK follows a progressive neurodegenerative course superimposed on a neurodevelopmental dysgenesis. Early infancy is characterized by global developmental delay, hypotonia, roving eye movements, microcephaly, and failure to thrive.[3][5][13][14] As children age, cerebral dysgenesis becomes evident on imaging, microcephaly progresses, and motor skills remain severely limited or regress.[5][9][10][13][14] Seizures may appear, and peripheral neuropathy manifests with areflexia and distal weakness.[3][5][9][14][15] Cutaneous ichthyosis and keratoderma develop and often worsen, leading to fissuring and pain.[11][15]

Malacards notes that “some patients may show developmental regression; many die in childhood,” and that “the clinical symptoms of the patients progress with age.”[14][13] A dermatologic series reports a lifespan “fluctuating between neonatal lethality to 12 years, with the eldest patient reported in the literature reaching 19 years,” indicating severe and often rapidly progressive disease.[15] The rate of progression varies: some infants die in the neonatal period due to severe neurologic compromise or complications, while others survive into late childhood or adolescence with chronic disability.[4][13][15]

One can conceptualize disease stages as early (infancy, initial neurologic signs), intermediate (early childhood, emergence of cutaneous and neuropathic signs), and advanced (late childhood/adolescence, complications and end‑stage disability). However, no formal staging system exists, and progression is best described qualitatively. The overall course is chronic and lifelong, with no spontaneous remission.[3][4][13][14][15]

8.3 Disease Duration, Course Patterns, and Critical Periods

CEDNIK is a lifelong condition with limited life expectancy, often ending in childhood or adolescence. Malacards and dermatologic series suggest that death usually occurs between ages 5 and 12, commonly due to aspiration pneumonia, although some patients die earlier and one reached 19 years.[14][15] Thus, disease duration ranges from months to under two decades, depending on severity and management.

Course patterns are primarily progressive rather than episodic or relapsing‑remitting. There may be periods of relative stability, but underlying neurologic and dermatologic deficits do not improve and often worsen over time.[4][13][15] No treatment‑induced remissions have been reported, and the absence of curative therapy means that prognosis is driven mostly by natural history and supportive care.

Critical periods include early infancy, when decisions about feeding support and respiratory management can influence survival, and early childhood, when cutaneous manifestations become evident and may provide diagnostic clues. Neuro‑ichthyotic reviews emphasize that recognition of CEDNIK based on early skin findings can facilitate genetic diagnosis and family counseling.[13][15] Another critical period is the window for reproductive decision‑making among carrier parents, where genetic counseling and prenatal diagnosis can prevent recurrence.[3][4][17]

9. Inheritance Pattern and Population Genetics

9.1 Inheritance Pattern, Penetrance, and Expressivity

CEDNIK syndrome is inherited in an autosomal recessive pattern. OMIM explicitly states that the transmission pattern in reported families is autosomal recessive, and Orphanet categorizes CEDNIK as a recessively inherited disease.[3][6] In all published cases, affected individuals carry homozygous or compound heterozygous pathogenic variants in SNAP29, while parents and many siblings are heterozygous carriers without clinical manifestations.[3][5][10][11][9] Mah‑Som et al. confirmed autosomal recessive inheritance in their cohort of 19 individuals from 10 families.[9][3]

Penetrance appears complete for core neurologic features among individuals with biallelic loss‑of‑function SNAP29 variants; all such patients have severe global developmental delay, hypotonia, and cerebral dysgenesis.[3][4][9][11][15] However, expressivity is variable for dermatologic and peripheral neuropathy features. Malacards notes that “the dermatologic features and peripheral neuropathy show reduced penetrance and are more variable manifestations of this disorder, as they are not observed in all patients with biallelic SNAP29 mutations.”[14] Mah‑Som et al. also observed variability in skin and neuropathy manifestations across their cohort.[9] The dermatologic series, however, found ichthyosis in 100% of 20 patients, suggesting high penetrance when careful dermatologic evaluation is performed; keratoderma was present in 85%, indicating partial penetrance.[15]

Genetic anticipation—progressively earlier onset or more severe disease in successive generations—has not been described, consistent with the absence of repeat expansions. Germline mosaicism has not been reported but cannot be conclusively excluded; however, the autosomal recessive pattern and consanguineous marriages make de novo events less likely.[3][11][9] Overall, CEDNIK is a severe, early‑onset, recessive disorder with complete penetrance of neurologic features and variable expressivity of dermatologic and neuropathic features.

9.2 Founder Effects, Consanguinity, and Carrier Frequency

The original families described by Sprecher et al. were consanguineous Arab families with multiple affected children carrying the same homozygous c.220delG mutation, suggesting a possible founder effect in that population.[11][3] Subsequent reports have identified distinct truncating variants in Pakistani, Iranian, and South‑Indian patients, indicating that CEDNIK arises from multiple independent mutations rather than a single global founder allele.[5][10][4][9][15] Nonetheless, local founder effects may exist within specific ethnic groups or regions where consanguinity is common.

Consanguinity plays a crucial role in CEDNIK epidemiology. Most reported families are consanguineous, and homozygosity mapping was used to identify the causal region on chromosome 22 in the original report.[11][3] The autosomal recessive inheritance pattern means that consanguineous unions increase the likelihood of homozygous SNAP29 variants, and CEDNIK appears to be enriched in populations with high consanguinity rates.[5][10][9][14][15] Carrier frequency in the general population is unknown but is likely extremely low given the rarity of the disease (<1/1,000,000).[14] In local communities where mutations have arisen, carrier frequency may be higher, particularly within extended families.

9.3 Epidemiology: Prevalence, Incidence, and Demographics

CEDNIK syndrome is an ultra‑rare disorder. Malacards estimates a prevalence of less than 1 per 1,000,000 worldwide.[14] Orphanet and GARD describe CEDNIK as rare, and OMIM notes that only a small number of patients have been reported in the literature.[1][3][6] Early reports mentioned 7 patients in the initial Arab family cohort.[11] A subsequent review noted 12 patients of Arab and Pakistani origin.[5] An Iranian case report added the “first documented Iranian patient” and noted that “so far, only 14 cases of this condition have been reported globally.”[10] Neurology Genetics expanded the cohort to 19 individuals from 10 families.[9] The dermatologic series analyzed 20 patients, suggesting that the total number of reported cases is now on the order of a few dozen.[15]

Geographically, CEDNIK has been reported in the Middle East (Arab families), South Asia (Pakistan, India), and Iran, with possible cases elsewhere.[5][9][10][11][15] This distribution likely reflects both founder mutations and consanguinity patterns, as well as differential access to genetic diagnostics. Sex ratio appears roughly equal, with both male and female patients reported; no sex bias is mentioned in primary or secondary sources.[3][5][9][10][15] Age distribution centers on infancy and childhood: most diagnoses are made in early life, and mortality typically occurs before adulthood, although one patient reached age 19.[14][15] Incidence is unknown but is likely extremely low, given the small number of families and high severity.

10. Diagnostics

10.1 Clinical Evaluation: Signs, Symptoms, and Imaging

Clinical diagnosis of CEDNIK syndrome begins with recognition of a characteristic constellation of neurologic and dermatologic features. Early clues include global developmental delay, hypotonia, roving eye movements, microcephaly, and failure to thrive.[3][5][13][14] As cutaneous manifestations emerge, generalized ichthyosis and palmoplantar keratoderma strongly suggest a neuro‑ichthyotic syndrome.[11][13][15] Neuro‑ichthyotic reviews emphasize that the combination of neurologic disease and ichthyosis defines a heterogeneous group of inherited disorders, and that distinct constellations of features, including brain MRI abnormalities and peripheral neuropathy, help differentiate CEDNIK from other entities.[13]

MRI is critical. Radiologic abnormalities in CEDNIK include corpus callosum defects, cortical dysplasia, pachygyria, polymicrogyria, hypomyelination, and white matter loss.[5][9][10][13][14] The Indian case reported brainstem malformation as an additional finding.[5] Malacards summarizes MRI features as varying degrees of cerebral dysgenesis, absence of the corpus callosum, cortical dysplasia, hypomyelination, white matter loss, and signal anomalies suggestive of leukodystrophy.[14] These imaging findings, combined with clinical signs, strongly support suspicion of CEDNIK in the appropriate context.

Electrophysiologic tests, including EEG and nerve conduction studies, can detect seizures and peripheral neuropathy but are not pathognomonic.[5][10] Biopsy of skin reveals retention hyperkeratosis, abnormal lamellar granules, and mislocated lipids and proteases, confirming a trafficking defect.[11][12][15] Histopathologic findings may overlap with other ichthyoses, but the combination of neurodevelopmental deficits and SNARE‑related lamellar granule abnormalities is characteristic.[11][12]

10.2 Genetic Testing Strategies

Definitive diagnosis of CEDNIK syndrome requires identification of biallelic pathogenic variants in SNAP29. Whole‑exome sequencing (WES) has become the standard approach, particularly in children with unexplained neurodevelopmental delay, cerebral malformations, and skin disease.[4][5][9][10] The expanded phenotypic spectrum study notes that “standard diagnosis of CEDNIK syndrome is made through whole exome genetic testing, with the presence of neuropathy, keratoderma, and ichthyosis serving as important diagnostic clues.”[4] In the Indian and Iranian cases, clinical exome sequencing identified homozygous frameshift variants in SNAP29, which were then confirmed by Sanger sequencing.[5][10]

Single‑gene testing for SNAP29 is appropriate in families with known mutations or in patients whose clinical and MRI features strongly suggest CEDNIK.[3][11][17] Gene panels for neurocutaneous or neuro‑ichthyotic syndromes may include SNAP29 along with other relevant genes (e.g., ABHD5, CERS3, PNPLA1, VPS33B), allowing differential diagnosis.[13][14][15] Chromosomal microarray (CMA), karyotyping, and FISH are not sufficient to detect most CEDNIK‑causing variants, as these are small indels or point mutations, though they may rule out other chromosomal syndromes.[3][10] Whole‑genome sequencing (WGS) could detect noncoding variants or structural changes but has not been routinely applied specifically for CEDNIK; WES currently provides higher yield for cost.[4][9][10]

ClinVar and GTR (Genetic Testing Registry) list SNAP29 tests for CEDNIK syndrome, including targeted variant analysis and full gene sequencing.[17][3] Interpretation follows ACMG/AMP guidelines, with frameshift and nonsense mutations considered pathogenic in the context of CEDNIK’s LoF mechanism.[3][5][10][11][9] Variants of uncertain significance, such as c.-76G>A, require caution and should not be considered diagnostic without supporting functional or segregation data.[17]

10.3 Omics‑Based Diagnostics and Biomarkers

Currently, no omics‑based diagnostic biomarkers beyond genetic sequencing are validated for CEDNIK. RNA sequencing, proteomics, metabolomics, and epigenomics have not been systematically used to diagnose or stratify CEDNIK patients.[12][15][16] In vitro studies of SNAP29 function in fibroblasts and keratinocytes provide mechanistic insights but are not part of standard clinical work‑up.[12][11][15]

However, one could envision future biomarkers based on lipidomics of the stratum corneum (e.g., glucosylceramide retention) or proteomics of lamellar granule cargo (e.g., kallikrein content) in skin biopsies.[15][12] Circulating biomarkers of autophagy or SNARE dysfunction might also be considered, though none have been proposed. For now, genetic testing of SNAP29 remains the central diagnostic tool, and no FDA‑approved biomarkers or BEST (Biomarkers, EndpointS, and other Tools) entries exist for CEDNIK.

10.4 Clinical Criteria and Differential Diagnosis

No formal diagnostic criteria or scoring systems (e.g., DSM, ICD‑11) exist specifically for CEDNIK syndrome. Diagnosis relies on clinical gestalt: a child with severe global developmental delay, cerebral dysgenesis on MRI, ichthyosis, palmoplantar keratoderma, and peripheral neuropathy should prompt consideration of CEDNIK and genetic testing for SNAP29.[3][4][11][13][14][15] Neuro‑ichthyotic syndromes with overlapping features must be considered in differential diagnosis, including:

Arthrogryposis‑renal dysfunction‑cholestasis (ARC) syndrome, caused by VPS33B mutations, which presents with neurodevelopmental delay, ichthyosis in half of patients, and early lethality but distinct renal and hepatic features.[13]

Other neuro‑ichthyoses such as Sjögren–Larsson syndrome (ALDH3A2), trichothiodystrophy, and leukodystrophies, which have unique MRI patterns, hair abnormalities, or metabolic profiles.[13]

KID (keratitis‑ichthyosis‑deafness) syndrome, characterized by vascularizing keratitis, sensorineural deafness, and specific cutaneous lesions.[13]

Differentiation relies on careful evaluation of associated features, MRI patterns, and genetic testing. For instance, CEDNIK patients typically do not have cholestasis or renal dysfunction seen in ARC syndrome, and their MRI shows cerebral dysgenesis with corpus callosum anomalies, rather than the distinct leukodystrophy patterns of some other neuro‑ichthyoses.[5][9][10][13][14]

10.5 Screening and Early Detection

There are currently no population‑based screening programs for CEDNIK syndrome, reflecting its extreme rarity and the absence of specific biochemical markers.[3][4][6][14] Newborn screening panels do not include CEDNIK or SNAP29 testing. However, carrier screening and prenatal diagnosis are important in high‑risk families

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	7
Resolved	6
Unresolved (possible confabulation)	1
Unverifiable	0
References weighed for topical relevance	6
On topic	4
Off topic	0

Unresolved references

These identifiers did not resolve to a record and may be fabricated. A lookup that failed for transport reasons is indistinguishable from one that failed because the record does not exist, so spot-check before acting on them:

PMC:PMC8965947 (1 mention) - Identifier did not resolve to a record

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	78
Resolved	71
Unresolved (possible confabulation)	4
Obsolete	2
Unverifiable	1
Terms whose name was checked	41
Terms named correctly	23
Terms named as a different term	11
Terms whose name is worth a second look	7

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

MONDO:0012290 (5 mentions) - the report calls it "genetic disease", "CEDNIK syndrome"; MONDO calls it CEDNIK syndrome
HP:0000988 (1 mention) - the report calls it "xerosis cutis"; HP calls it Skin rash
HP:0000999 (1 mention) - the report calls it "hyperkeratosis"; HP calls it Pyoderma
HP:0000268 (1 mention) - the report calls it "facial dysmorphism"; HP calls it Dolichocephaly
HP:0000280 (1 mention) - the report calls it "synophrys"; HP calls it Coarse facial features
HP:0000546 (1 mention) - the report calls it "nystagmus"; HP calls it Retinal degeneration
HP:0000579 (1 mention) - the report calls it "optic nerve hypoplasia"; HP calls it Nasolacrimal duct obstruction
HP:0000736 (1 mention) - the report calls it "abnormal behavior"; HP calls it Short attention span
GO:0048812 (1 mention) - the report calls it "epidermal cell differentiation"; GO calls it neuron projection morphogenesis
GO:0036064 (1 mention) - the report calls it "cilium organization"; GO calls it ciliary basal body
GO:0031017 (1 mention) - the report calls it "lamellar body"; GO calls it exocrine pancreas development

Unresolved terms

These identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:

HP:0007568 (1 mention), reported as "palmoplantar keratoderma" - HP does not contain this term
HP:0007113 (2 mentions) - HP does not contain this term
HP:0003439 (2 mentions) - HP does not contain this term
HP:0000427 (1 mention), reported as "epicanthal folds" - HP does not contain this term

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

UBERON:0001025 (obsolete synapse) (1 mention)
UBERON:0000944 (obsolete dorsal branch) (1 mention)

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

HP:0007556 (3 mentions) - the report calls it "palmoplantar keratoderma"; HP calls it Plantar hyperkeratosis, and lists "Plantar hyperkeratoses" among its other names
HP:0000444 (1 mention) - the report calls it "depressed nasal bridge"; HP calls it Convex nasal ridge
HP:0000733 (1 mention) - the report calls it "stereotypy"; HP calls it Motor stereotypy, and lists "Stereotyped" among its other names
GO:0030992 (1 mention) - the report calls it "intraciliary transport"; GO calls it intraciliary transport particle B
GO:0005484 (1 mention) - the report calls it "SNARE binding"; GO calls it SNAP receptor activity, and lists "SNARE" among its other names
GO:0007268 (1 mention) - the report calls it "synaptic transmission"; GO calls it chemical synaptic transmission, and lists "synaptic transmission" among its other names
GO:0005773 (1 mention) - the report calls it "vacuole/lysosome"; GO calls it vacuole

Terms named inconsistently

The report gives these identifiers more than one name of its own:

MONDO:0012290 - called "genetic disease", "CEDNIK syndrome"

Ask OpenScientist

OpenScientist Report

Mappings

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

1. Disease Information

1.1 Definition and Concise Overview

1.2 Key Disease Identifiers and Ontology Mapping

1.3 Synonyms and Alternative Names

1.4 Nature of the Information: Case‑Based versus Aggregated Resources

2. Etiology and Risk Factors

2.1 Primary Causal Factors: Genetic Basis in SNAP29

2.2 Genetic Risk Factors: Causal Variants, Susceptibility, and Modifiers

2.3 Environmental and Lifestyle Risk Factors

2.4 Protective Factors

2.5 Gene–Environment Interactions

3. Phenotypic Spectrum and Clinical Manifestations

3.1 Overview of Phenotypic Domains

3.2 Neurologic and Developmental Phenotypes

3.3 Cutaneous Phenotypes: Ichthyosis and Keratoderma

3.4 Craniofacial and Growth Phenotypes

3.5 Sensory Phenotypes: Ocular and Auditory Involvement

3.6 Behavioral and Neuropsychiatric Phenotypes

4. Genetic and Molecular Information

4.1 Causal Gene: SNAP29 (Synaptosomal‑Associated Protein 29)

4.2 Pathogenic Variants: Types, Locations, and Functional Consequences

4.3 Allele Frequency, Somatic versus Germline Origin

4.4 Modifier Genes and Epigenetic Information

4.5 Chromosomal Abnormalities and Structural Genomics

5. Environmental Information

5.1 Non‑Genetic Contributing Factors

5.2 Lifestyle Factors and Infectious Agents

6. Mechanisms and Pathophysiology

6.1 Ordered Causal Chain from Mutation to Clinical Phenotype

6.2 Molecular Pathways: SNARE‑Mediated Trafficking, Autophagy, and Ciliogenesis

6.3 Cellular Processes: Endocytosis, Recycling, Autophagy, and Epidermal Differentiation

6.4 Protein Dysfunction: Loss‑of‑Function SNARE Defect

6.5 Metabolic and Biochemical Abnormalities

6.6 Immune System Involvement and Tissue Damage Mechanisms

6.7 Molecular Profiling and Advanced Technologies

6.8 Cell Types and Biological Processes: Ontology Suggestions

7. Anatomical Structures Affected

7.1 Organ‑Level Involvement

7.2 Tissue and Cell‑Level Targets

7.3 Subcellular Compartments

7.4 Localization and Lateralization

8. Temporal Development and Natural History

8.1 Age of Onset and Onset Pattern

8.2 Disease Progression, Stages, and Rate

8.3 Disease Duration, Course Patterns, and Critical Periods

9. Inheritance Pattern and Population Genetics

9.1 Inheritance Pattern, Penetrance, and Expressivity

9.2 Founder Effects, Consanguinity, and Carrier Frequency

9.3 Epidemiology: Prevalence, Incidence, and Demographics

10. Diagnostics

10.1 Clinical Evaluation: Signs, Symptoms, and Imaging

10.2 Genetic Testing Strategies

10.3 Omics‑Based Diagnostics and Biomarkers

10.4 Clinical Criteria and Differential Diagnosis

10.5 Screening and Early Detection

Reference Validation

Unresolved references

Term Validation

Terms the report names something else

Unresolved terms